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Abstract 
 
Nanette R. Lee: Estimating the effects of overweight duration, sodium intake and genetic 
variants on hypertension risk among Filipino women in Cebu, Philippines 
(Under the direction of Dr. Linda S. Adair) 
 
Hypertension makes the largest contribution to the worldwide burden of 
cardiovascular diseases. It is a multi-factorial disease that develops from the complex 
interplay of environmental and genetic factors. Asians are a special concern because they 
tend to develop hypertension at a lower body mass index (BMI) compared to Caucasian 
populations and have been reported to consume high amounts of sodium. This research 
examined the roles of overweight duration, variants of the angiotensinogen (AGT 
Met235Thr), angiotensin converting enzyme (ACE insertion/deletion (I/D) in intron 16) and 
alpha adducin (ADD1 Gly460Trp) genes, and high sodium consumption on hypertension risk 
among adult Filipino women in Cebu, Philippines. Additionally, this research explored 
potential heterogeneity of effects according to different genetic and environmental 
characteristics. We used data gathered by the Cebu Longitudinal Health and Nutrition Survey 
(CLHNS). Aside from detailed individual, household and community level socio-
demographic characteristics, this data contained genetic information, repeated 
anthropometric measures that span over two decades, dietary measures including sodium 
intake, and repeated blood pressure measurements. Using poisson regression with robust 
error variance, we found that overweight duration influenced the 5-year cumulative incidence 
(2002-2007) of hypertension independent of 2002 BMI.  Results of logistic regression 
analyses showed that AGT Met235Thr appeared to influence hypertension risk 
 iv 
regardless of age, BMI and presence of the other variants. We found possible age-dependent 
effects for the ACE and ADD1 variants. Our findings also suggest that the effect of high 
sodium intake on hypertension is: (1) enhanced in women with the ADD1 TrpTrp genotype 
but not evident in women with the GlyGly or GlyTrp genotypes; (2) increased with 
increasing age, in women who had never been overweight and those who were smokers; and 
(3) decreased with increasing BMI. Overall, this research found that the duration of being 
overweight, selected genetic variants and sodium intake may influence hypertension risk in 
adult Filipino women. We observed potential heterogeneity of effects and support the 
importance of conducting context-dependent analyses. Results of this research may be used 
to design a more comprehensive hypertension prevention program in the Philippines and 
possibly in other Asian and developing countries.   
     
 
 
 
 
 
 
 
 
 
 
 
 v
To my family. 
 vi 
Acknowledgements 
  
 My heartfelt gratitude to my advisor, Dr. Linda Adair, for her guidance and unfailing 
support. I am eternally grateful for her belief in this project and my capabilities, especially in 
my toughest and lowest moments. She is an ideal mentor and an inspiration. Without her, this 
study will not be possible.  I want to thank the members of my dissertation committee for 
their invaluable contributions to this project. Dr. Barry Popkin, for letting me see the bigger 
picture, Dr. Karen Mohlke for helping me explore the area of genetics, Dr. Ka He for his 
attention to detail and Dr. Chirayath Suchindran for his statistical expertise. I also want to 
acknowledge Amanda Marvelle for genotyping, Paulita Duazo for putting together the 
dietary data and the staff of the Office of Population Studies Foundation in Cebu for their 
longstanding work on the CLHNS. I appreciate the words of kindness and encouragement of 
my family and friends from the Philippines and US. I am especially indebted to Judith Borja 
and Adrian Serohijos for their intellectual and emotional support. I thank my father, Virgilio 
Lee, for his unquestioning belief in me and for never failing to boost my confidence in all my 
endeavors. Most importantly, I thank God who accomplishes all things for me.   
This study was funded by the following NIH grants: R01 HL085144 (Obesity 
Development and CVD Risk Factor Clustering in Filipino Women & Offspring); R01 
DK078150 (Genetic Epidemiology of Body Mass Index, Adiposity and Weight Gain); and 
5D43TW000633 (Fogarty International Center: International Training and Research in 
Population and Health). 
 vii
Table of Contents 
 
 
List of Tables…………..………..…..…………………………………………………….…..x 
List of Figures……………….………………………………………………………………..xi 
List of Abbreviations………..……………………………………………………………….xii 
I.   Introduction….……..……………………………………………………………………...1 
A.  Background………………………...………………………………………………….1 
B.  Overall objectives and specific aims…...……………………………………………...2 
II.  Literature review……….………………………………………………………………….5 
A.  Scope of the problem…………………...……………………………………………..5 
B.  Factors associated with hypertension………………………………………………….8 
B.1. BMI, overweight duration and hypertension…….……………………………….9 
B.2. Genetic variants and hypertension………………..…………………………….11 
B.3. Sodium intake and hypertension………………………………………………..15 
C.  Summary and significance…………………………………………………………...17 
III. Overweight duration and incidence of hypertension in Filipino women ...…………....19  
A.  Abstract…..…….…………………………………………………………………….19 
B.  Introduction..….……………………………………………………………………...20 
C.  Methods…….………..……………………………………………………………….22 
C.1. Data source and sample.………………………………………………………...22 
C.2. Analysis variables..….…..…………………..………………….……………....23
 viii 
            C.3. Statistical analysis…….………………………………………………………...25 
D.  Results…….………………………………..………..…………………………….…26 
E.  Discussion….…………………………………………..………………………..……27 
IV. Effects of  ACE and ADD1 polymorphisms on the prevalence of hypertension 
in Filipino women are modified by age………………………………………………….37  
A.  Abstract………………………..…….……………………………………………….37 
B.  Introduction……………………..…….……………………………………………...38 
C.  Methods……………………………..….…………………………………………….41 
C.1. Data source and sample ………………………………………………………...41 
C.2. Analysis variables…….………………………………...………………….….. 41 
C.3. Genotyping…………...……………………………………………….………...43 
C.4. Statistical analysis…….………………………………………………………...44 
D.  Results..……………………………………..……………………………….…….…45 
E.  Discussion……….……………………………………………………………………46 
V.  The association between high sodium intake and hypertension in Filipino  
women is influenced by genetic and environmental factors.…………..…………….…..55  
A.  Abstract………………………………………………………………..………….….55 
B.  Introduction…………………………………………………………………………..56 
C.  Methods………………………………..……………………….…………………….58 
C.1. Data source and sample ………………………………………………………...58 
C.2. Analysis variables..….…..…………………..………..………………………...59 
C.3. Statistical analysis…….………………………………………………………...62 
D.  Results………..….…………………………..…………………………………….…63 
E.  Discussion………..………………………………………………….…………..……65 
VI. Synthesis………………………...………………………….……………...…………….80 
 ix 
A.  Overview of findings….…..……………………………….….……………………..80 
A.1. Overweight duration increased the five-year cumulative incidence of  
        hypertension regardless of current weight status in Filipino women………..…81 
 
A.2. Genetic variants influence hypertension risk in Filipino women……..………..83 
 
A.3. The association between high sodium intake and hypertension in Filipino  
        women is influenced by genetic and environmental factors………..…………..84 
 
B.  Limitations and strengths…………………………………….………………………85 
C.  Public health significance…………………………………….………………………87 
D.  Direction for future research…………………………………………………………89 
 
References……………………………………………………………………………………92
 x
List of Tables 
 
Table 3.1. Characteristics of non-pregnant, non-hypertensive Cebu women in  
the 2002 survey, by overweight (OW) duration….…………..……………...………………33 
 
TABLE 3.2. Cumulative incidence ratios (95% CI) for hypertension according  
to overweight (OW) duration in adult Cebu women, 2002-2007…………….……………...34 
 
Table 4.1. Selected characteristics of CLHNS women in 2005, N=1776…………………...52 
 
Table 4.2. Effects of AGT, ACE and ADD1 polymorphisms on odds of  
hypertension, by age…………………………………………………………………………53 
 
Table 5.1. Percent distribution of sodium sources among women in 2005……….…………74 
 
Table 5.2. Selected characteristics of women in 2005, by sodium intake.………….……….75 
 
Table 5.3. Odds ratios (95% CI) for hypertension comparing high to low  
sodium intake (reference) among women, by ADD1 genotype, OW duration,  
and smoking status…………………………………………………….……………………..76 
 
Table 5.4. Odds ratios (95% CI) for hypertension comparing high to low  
sodium intake (reference) among women stratified by BMI and OW duration  
categories, by ADD1 genotype………………………………………………………………77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xi 
List of Figures 
Figure 3.1. Trend in overweight (OW) prevalence from 1983/84 to 2002  
among Cebu women who were not hypertensive in 2002…………………………………...35 
 
Figure 3.2. Percent distribution of Cebu women by overweight (OW) duration  
in the 2002 survey (gray bars) and corresponding five-year cumulative incidence  
(per 100 persons at risk) of hypertension for each OW duration group (dots with  
error bars representing 95% confidence interval)……………………………………………36 
 
Figure 4.1. Odds of hypertension comparing genotypes at selected ages.  
(A) ACE (rs4331) II vs DD/DI and (B) ADD1 (rs4961) GlyTrp/TrpTrp vs GlyGly…….…..54 
 
Figure 5.1. Estimated odds ratios with 95% confidence intervals (CI) for  
hypertension comparing women with high sodium intake to women with  
low sodium intake (reference) at selected ages……….……………………….……….…….78 
 
Figure 5.2. Estimated odds ratios with 95% confidence intervals (CI) for  
hypertension  comparing women with high sodium intake to women with  
low sodium intake (reference) at selected body mass indices (BMI)……………..…….…...79 
 
 
 
 xii
List of Abbreviations 
ACE angiotensin converting enzyme 
ADD1 alpha adducin 
AGT angiotensinogen 
BP blood pressure 
CI confidence interval 
CLHNS 
DALY 
Cebu Longitudinal Health and Nutrition Survey 
disability adjusted life years 
DASH Dietary Approaches to Stop Hypertension 
I/D insertion/deletion 
FNRI Food and Nutrition Research Institute 
Gly/Trp glycine/tryptophan 
IR incidence ratio 
kcal kilocalorie 
kg kilogram 
LDL-C low density lipoprotein cholesterol 
m meter 
MAP mean arterial pressure 
mEq milli-equivalent 
Met/Thr methionine/threonine 
mg milligram 
MSG monosodium glutamate 
OR odds ratio 
 xiii 
OW overweight 
RAAS renin-antiontensin-aldosterone system  
RAS renin angiotensin system 
WHO World Health Organization 
  
 
 
 
I. Introduction 
 
A.  Background 
Cardiovascular diseases (CVD) are the leading causes of morbidity and mortality in 
the world. They account for 10% of the world’s disability adjusted life years (DALYs) and 
30% of all deaths (WHO 2002; Mackay and Mensah 2004; Lopez, Mathers et al. 2006). 
Among the known CVD risk factors, hypertension makes the largest contribution to the CVD 
burden accounting for almost half of all CVD-related deaths (Mackay and Mensah 2004; 
Lawes, Vander Hoorn et al. 2006; Lopez, Mathers et al. 2006). Alarmingly, the prevalence of 
hypertension continues to rise, especially in lower income countries that are overburdened by 
both communicable and chronic diseases (WHO 2002; WHO 2005; Lopez, Mathers et al. 
2006; Kengne, Patel et al. 2007). The World Health Organization (WHO) projects the 
proportion of CVD-related DALYs for high income countries to remain steady while that for 
low- and middle-income countries to rise sharply, further widening health disparities (WHO 
2002; WHO 2005). 
Hypertension is a complex multifactorial disease caused by the combined actions of 
genetic and environmental factors (Lifton 1996; Arnett 2007). Few studies have examined 
the interaction of these factors and fewer have looked at their effects in populations of 
developing Asian countries that are plagued with increasing levels of obesity and rapidly 
changing food environments (Popkin, Horton et al. 2001; Adair 2004). The information gap 
may be due to the lack of population-based studies with adequate depth and detail. There is a 
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paucity of information on adiposity trends derived from longitudinal studies and there are 
inadequate dietary and genetic data, especially among Asians who tend to develop CVD risk 
factors at lower body mass index (BMI) thresholds (Colin Bell, Adair et al. 2002; WHO 
2004; Nguyen, Adair et al. 2008). In addition, sodium consumption, which can increase 
hypertension risk, has been found to be high in this population (INTERSALT 1988; FNRI-
DOST 2000; WHO 2007). The demographic and health trends in the Philippines exemplify 
those of other developing Asian countries undergoing the nutrition transition: (a) heart and 
vascular diseases are the leading causes of death in the country (DOH 2007); and (b) there is 
a high prevalence (with an increasing trend) in CVD risk factors including excess weight and 
hypertension (FNRI 2006). Thus, examining the influence of overweight (OW) history, 
sodium intake and genetic variants in an Asian population from a transitional country such as 
the Philippines can provide critical information necessary for a better understanding of the 
mechanisms leading to the development of a complex and deadly disease such as 
hypertension and can potentially guide more tailored hypertension prevention efforts. 
 
B. Overall objective and specific research aims  
The study aimed to understand how OW duration, sodium intake, and selected genetic 
variants independently and jointly affect hypertension risk among adult Filipino women 
(ages 35 to 68 yr in 2005) using the Cebu Longitudinal Health and Nutrition Survey 
(CLHNS), an ongoing community-based study which began in 1983. Specific aims and 
hypotheses were as follows: 
1. Determine the effect of OW duration on the 5-year cumulative incidence of 
hypertension. We examined patterns of OW from 1983/84 to 2002 to determine 
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whether a more recent change or a longer history of being OW might be more 
influential in developing hypertension from 2002 to 2007. We hypothesized that 
duration of OW is positively associated with having hypertension independent of 
current weight status. To assess this relationship, we used poisson regression with the 
robust error variance.  
2. Determine the effects of selected genetic variants on hypertension risk. We aimed 
to examine the effects of AGT Met235Thr, ACE insertion/deletion (I/D) in intron 16, 
and ADD1 Gly460Trp polymorphisms on the risk of hypertension in Filipino women. 
Additionally, we aimed to explore the heterogeneity of the effects of these three 
genetic variants according to different genetic and environmental contexts by looking 
at potential gene-gene, gene-age and gene-BMI interactions. We hypothesized that 
these variants influence hypertension risk and that their effects vary according to age, 
BMI and the presence of the other variants. To achieve our aims we used logistic 
regression analysis and tested heterogeneity of effects through likelihood ratio tests.  
3. Estimate the effect of high sodium intake on hypertension risk. We determined 
the association between high sodium intake (≥4600 mg/day) and hypertension in 
Filipino women and examined whether there is heterogeneity in the effect of sodium 
intake according to different genetic and environmental characteristics. For the 
genetic characteristics, we specifically sought to assess effect measure modification 
by the genetic variants that we investigated in the second aim: AGT Met235Thr, ACE 
I/D, and ADD1 Gly460Trp. For the environmental characteristics, we aimed to 
examine the potential modifying role of age, BMI, OW duration, and smoking status. 
We hypothesized that high sodium intake is positively associated with hypertension 
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risk in Filipino women and further, that its effect is not homogenous across women 
with different characteristics. To answer our research questions, we used logistic 
regression analysis and tested heterogeneity of effects through likelihood ratio tests.
  
 
 
 
II. Literature review 
 
This section presents the scope of the problem, reviews the literature on specific 
topics covered by the aims of the study, and summarizes the limitations of previous studies 
and strengths of the current study.     
 
A. Scope of the problem 
Currently, cardiovascular diseases (CVD) are the leading causes of morbidity and 
mortality not only in developed countries but also in developing countries (WHO 2002; 
Mackay and Mensah 2004; WHO 2005; Lopez, Mathers et al. 2006; Arnett, Baird et al. 
2007; WHO 2007; Lawes, Vander Hoorn et al. 2008).  CVDs are responsible for 30% of all 
deaths (Mackay and Mensah 2004; WHO 2005; Lopez, Mathers et al. 2006) and are major 
contributors to the global burden of disease accounting for: (a) 10% of disability adjusted life 
years (DALYs) globally; (b) 20% of DALYs in high income countries; and, (c) 8% of 
DALYs in low and middle income countries (WHO 2002; WHO 2005).  
Among the known CVD risk factors, hypertension makes the largest contribution to 
the CVD burden accounting for almost half of all CVD-related deaths (Mackay and Mensah 
2004; Lawes, Vander Hoorn et al. 2006; Lopez, Mathers et al. 2006) and a third of CVD-
related DALYs (WHO 2002).  Of the estimated 16.7 million CVD-related deaths per year, 
about 8 million are attributed to hypertension (WHO 2002; Mackay and Mensah 2004).  In 
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2001, about 54% of stroke and 47% of ischaemic heart disease worldwide were attributable 
to high blood pressure (BP) (Lawes, Vander Hoorn et al. 2008).  
Further aggravating this issue is the seemingly parallel increase in obesity rates 
worldwide. In the US, age-adjusted obesity prevalence tripled among adolescents (from 5 to 
16%) and doubled among children (from 7 to 16%) and adults (from 15 to 31%) in the last 2 
decades (CDC/NCHS 2002). These increases are observed regardless of gender, age or 
race/ethnicity (Flegal, Carroll et al. 2002). In developing countries, the proportion of 
overweight (OW) individuals has exceeded the proportion of underweight (Mendez, 
Monteiro et al. 2005). This scenario poses a major public health concern since OW and/or 
obesity can lead to grave consequences – (a) it is significantly associated with increased 
incidence of hypertension, diabetes mellitus, hypercholesterolemia, asthma, arthritis, poor 
health status, and some forms of cancer; and, (b) it is one of the leading causes of death 
(Mokdad, Ford et al. 2003; Mackay and Mensah 2004). According to WHO (2002), 
approximately 58% of diabetes, 21% of ischaemic heart disease, and 8 to 42% of certain 
cancers globally were attributable to a body mass index (BMI) above 21 kg/m2 (WHO 2002). 
Developing countries bear most of the burden caused by CVD-related mortality and 
morbidities. Approximately 80% of the burden attributed to high BP is borne by low- and 
middle-income countries (Lawes, Vander Hoorn et al. 2008). Moreover, the proportion of 
DALY attributed to CVDs for high income countries is projected to remain steady while 
those for low- and middle-income countries are projected to rise sharply (WHO 2002). Asian 
population is of special concern because they have the most rapid increases in obesity and 
obesity-related diseases worldwide (Popkin, Horton et al. 2001; Mendez, Monteiro et al. 
2005), and they tend to develop CVD risk factors at lower BMI thresholds (Colin Bell, Adair 
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et al. 2002; WHO 2004; Nguyen, Adair et al. 2008).  For example, it was shown that Filipino 
women had higher prevalence of hypertension compared with non-Hispanic Whites and 
Mexican Americans at all levels of BMI and that the BMI-hypertension association among 
Chinese men was stronger compared with non-Hispanic Whites at BMI levels less than 25 
kg/m2 (Colin Bell, Adair et al. 2002). This may be attributed to the observation that Asians 
tend to have higher percent body fat and central adiposity, given the same BMI (Deurenberg-
Yap, Chew et al. 2002; Deurenberg, Deurenberg-Yap et al. 2002). In addition, sodium 
consumption, which can increase hypertension risk, has been found to be high in this 
population (INTERSALT 1988; FNRI-DOST 2000; WHO 2007). These alarming scenarios 
contribute to the widening global health disparities as they additionally stretch the already 
limited health resources of these countries.  
Along with other developing countries, the Philippines with a population of over 88 
million has been undergoing rapid socio-economic changes. Accompanying these 
developments are the changing food environment (shift from traditional to western diets) as 
well as the increasing prevalence of non-communicable diseases, particularly CVDs. In 2003, 
heart diseases, vascular system diseases and diabetes were among the leading causes of death 
in the country (DOH 2007). Philippine national survey data showed high prevalence with 
increasing trend of CVD risk factors: from 1998 to 2003, the proportion of adult Filipinos 
with total cholesterol >200 mg/dL increased from 16 to 28%, those with low density 
lipoprotein cholesterol (LDL-C) >130 mg/dL increased from 28 to 32%, and hypertension 
prevalence slightly increased from 21 to 23%. The proportion of adult women having a 
waist-to-hip ratio >0.85, a level associated with increased risk of hypertension and diabetes, 
increased from 40 to 55% and the prevalence of OW increased from 23 to 27% (FNRI 2001; 
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FNRI 2006).  In the US, CVD was reported as the leading cause of death among Filipino 
Americans, the largest subset of Asian Americans (NHLBI 2003). Examining CVD-related 
morbidities in societies like the Philippines that are transitioning toward developed country 
morbidity profiles can provide essential information necessary for designing interventions 
that can potentially narrow within-US and global health disparities.  
 
In summary, CVDs and obesity are serious health problems worldwide. The alarming 
levels and trends of CVD risk factors, including hypertension, suggest continuing increases 
in CVDs, especially in developing countries. These conditions underscore the need to 
examine factors associated with hypertension in a transitional country such as the Philippines 
that can potentially guide more targeted public health interventions. 
 
B. Factors associated with hypertension  
Hypertension is a multi-factorial, polygenic disease. The homeostatic control of BP is 
complex affecting a wide variety of physiologic systems – baroreceptors that sense acute 
changes in blood vessel pressure, natriuretic peptides produced in response to increased 
pressure in the brain and heart, renin-angiotensin-aldosterone system (RAAS) that influence 
vascular volume homeostasis and tone, kinin-kallikrein system that affects vascular tone and 
renal salt handling, adrenergic receptor system that influences heart rate, cardiac contraction 
and vascular tone, and those that are produced by blood vessels causing vasolidation or 
contraction (Lifton, Gharavi et al. 2001; Kaplan, Lieberman et al. 2002). Hypertension 
results from abnormalities in any of these factors or in the interactions of these factors that 
 9
can increase cardiac output and/or peripheral resistance (Krause, Winston et al. 1998; 
Kaplan, Lieberman et al. 2002).  
Factors associated with the development of hypertension involve a combination of 
genetic predisposition, and modifiable factors such as increasing weight with central 
distribution, unhealthy diet, and physical inactivity (Brown, Higgins et al. 2000; Janssen, 
Katzmarzyk et al. 2002; Mackay and Mensah 2004; WHO 2005; Narkiewicz 2006). This 
study covered key risk factors focusing on the influence of the duration of excess weight, 
genetic variants and high sodium intake, and explored potential interactions of their effects 
on hypertension risk.     
 
B.1. BMI, overweight duration and hypertension  
It is well documented that excess weight/fat increases the risk of CVDs. Adiposity 
measured through BMI or abdominal fat patterning reflected by waist-hip ratio or waist 
circumference has been associated with BP in both genders and across ethnicities (Must, 
Spadano et al. 1999; Brown, Higgins et al. 2000; Janssen, Katzmarzyk et al. 2002; Adair 
2004; Davy and Hall 2004).  In fact, a Framingham Heart Study data suggested that 65 to 
75% of the risk of hypertension may be attributed to excess weight (Garrison, Kannel et al. 
1987). Possible mechanisms involved in the excess weight-increased BP relationship include 
insulin resistance and hyperinsulinemia (Reaven, Lithell et al. 1996; Davy and Hall 2004), 
leptin resistance (Hall, Jones et al. 2003; Davy and Hall 2004; Berg and Scherer 2005; 
Mathew, Patel et al. 2007), activation of the sympathetic nervous and RAAS (Hall, Jones et 
al. 2003; Segura and Ruilope 2007), increased procoagulatory activity and endothelial 
dysfunction (Berg and Scherer 2005; Shankar and Steinberg 2005), subclinical inflammation 
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(Berg and Scherer 2005), and increased renal sodium re-absorption resulting in volume 
expansion (Hall, Jones et al. 2003; Wofford and Hall 2004; Mathew, Patel et al. 2007). 
Despite studies that suggest significant associations between obesity/OW duration 
and obesity-related morbidities such as insulin resistance (Ivandic, Prpic-Krizevac et al. 
1998; Muscelli, Camastra et al. 1998; Janssen, Katzmarzyk et al. 2004), type 2 diabetes 
mellitus (Everhart, Pettitt et al. 1992; Pontiroli and Galli 1998; Wannamethee and Shaper 
1999; Sakurai 2000; Janssen, Katzmarzyk et al. 2004; Wannamethee, Shaper et al. 2005), and 
left ventricular muscle hypertrophy which can accompany increased BP (Nakajima, Fujioka 
et al. 1985; Licata, Scaglione et al. 1992; Urbina, Gidding et al. 1995), few studies have 
investigated OW duration as a risk factor for hypertension. To our knowledge, only three 
studies have looked at the OW or obesity duration-hypertension association (Pontiroli and 
Galli 1998; Hekimsoy and Oktem 2003; Janssen, Katzmarzyk et al. 2004) and the results 
have been inconsistent. Janssen et al showed that the odds of having hypertension among 
women who were OW ≥ 10 years were double that of normal weight women (these results 
were not observed in men). Alternatively, the other two studies focused on obese patients and 
did not observe a significant association between obesity duration and hypertension 
(Pontiroli and Galli 1998; Hekimsoy and Oktem 2003). No studies have looked at this 
association in developing countries.  
The inconsistency in the findings of previous studies dealing with duration of OW 
and hypertension may be due to methodological differences. These studies were cross-
sectional and relied on self-reported or recalled weight, some relying on recalls as far back as 
more than 20-30 years (Pontiroli and Galli 1998; Hekimsoy and Oktem 2003; Janssen, 
Katzmarzyk et al. 2004). To define OW or obesity duration, none of these studies used 
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repeatedly measured weights. Effect estimates could have been biased since recalled weight 
is not independent of current BMI status, especially for OW/obese women who are more 
likely to underestimate self-reported or recalled weight (Perry, Byers et al. 1995; Troy, 
Hunter et al. 1995; Gillum and Sempos 2005; Brunner Huber 2007; Nyholm, Gullberg et al. 
2007; Shields, Gorber et al. 2008). Our study overcame this limitation by defining OW 
history and duration based on measured weights collected using the same protocols for about 
two decades of adult life. In addition, having measured BP in more than one time point 
allowed us to examine hypertension incidence. Longitudinal analysis of hypertension 
incidence can ensure that the entire duration of excess weight happened before the 
development of hypertension, thus lending more support for causation.  
 
B.2. Genetic variants and hypertension 
Looking at heritability estimates across studies and across populations, about 30% of 
the population variability in BP may be attributed to genetic factors (Ward 1995; Arnett, 
Baird et al. 2007). Candidate gene studies have shown evidence for association between 
specific genes and hypertension, albeit inconsistently (Luft 2004; Arnett, Baird et al. 2007). 
The scientific statement of the American Heart Association Council assessing the relevance 
of genetics and genomics for the prevention and treatment of CVD listed at least 30 
candidate genes associated with high BP and/or essential hypertension (Arnett, Baird et al. 
2007). However, recent genome wide association studies aiming to elucidate the genetic 
basis of hypertension have not been successful – no associations exceeded the criteria of 
statistical significance (p-value 5 X 10-7) (Levy, Larson et al. 2007; WellcomeTrust 2007). 
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Of the genes associated with BP, we focused on polymorphisms suggested to be 
involved in the development of high BP or hypertension. The renin-angiotensin system 
(RAS) is known to regulate BP by influencing vascular volume homeostasis and tone (Lifton, 
Gharavi et al. 2001). Considerable efforts have been made in investigating polymorphisms in 
genes encoding the main components of this system. Of the AGT gene polymorphisms linked 
to hypertension, the Met235Thr variant is one of the most widely examined (Binder 2007) 
and showed possible effect differences by race. Jeunemaitre et al  were the first to suggest the 
role of the AGT Met235Thr polymorphism in the development of hypertension (Jeunemaitre, 
Soubrier et al. 1992). Using data from 267 men and women of Northern and Western 
European descent, they showed that the ThrThr genotype was associated with an increase in 
plasma angiotensinogen and a 95% increase in the odds of hypertension compared to the 
MetMet genotype. Increased BP may be explained by the role of AGT in encoding the 
precursor molecule for angiotensin II which causes intense vasoconstriction and sodium re-
absorption in the kidney. However, results of the numerous studies that followed this 
pioneering work were not consistent. A case-control study involving 1476 subjects reported a 
null association between Met235Thr and hypertension (Kato, Sugiyama et al. 2000) but a 
meta-analyses involving 25055 individuals from 3 ethnicities (Whites, Blacks, Asians) 
concluded that AGT  Met235Thr was associated with increased risk of hypertension in 
Whites (OR: MetThr 1.08, ThrThr 1.19) and Asians (OR: MetThr 1.29, ThrThr 1.60) (Sethi, 
Nordestgaard et al. 2003).  
The I/D polymorphism of the ACE gene has also been suggested in the 
pathophysiology of hypertension, with the D allele associated with higher ACE levels and 
endothelial dysfunction and therefore increased BP (Luft 2004; Penesova, Cizmarova et al. 
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2006). This variant may be one of the most consistently linked polymorphisms to CVD in the 
general population; but, its association with hypertension has been less convincing (Niu, 
Chen et al. 2002; Luft 2004). ACE DD has been shown to influence hypertension risk with 
possible gender-specific effects (O'Donnell, Lindpaintner et al. 1998; Higaki, Baba et al. 
2000; Lynch, Arnett et al. 2007). For example, using a population-based sample of mostly 
Caucasian men and women (N=3095, Framingham Study), O’Donnell et al reported adjusted 
odds ratios (ORs (95% confidence interval)) for hypertension in 1445 men for the DD and DI 
genotypes as 1.59 (1.13-2.23) and 1.18 (0.87-1.62), respectively, versus II (O'Donnell, 
Lindpaintner et al. 1998). The corresponding ORs in 1650 women were 1.00 (0.70-1.44) and 
0.78 (0.56-1.09), respectively.  
The ADD1 Gly460Trp variant may cause hypertension by enhancing tubular sodium 
re-absorption in the kidney (Bianchi, Ferrari et al. 2005). The relationship between ADD1 
Gly460Trp polymorphism and hypertension in humans was first demonstrated by Cusi et al 
(Cusi, Barlassina et al. 1997). As with the other polymorphisms, results of studies that 
followed were inconsistent. For example, among Asians, Kato et al did not find a significant 
association between the 460Trp allele and hypertension in 507 Japanese (Kato, Sugiyama et 
al. 1998), Shin et al corroborated the negative finding examining 903 Koreans (Shin, Chung 
et al. 2004), but Huang et al found a significant association (OR: 1.43, p = 0.029) among 751 
Han Chinese (Huang, Sun et al. 2007).  
High risk genetic environments may be necessary for hypertension to develop. 
Studies have shown that the effects of the selected polymorphisms may only be evident when 
other genetic and environmental characteristics were taken into account (Barlassina, Schork 
et al. 2000; Svetkey, Moore et al. 2001; van der Kleij, de Jong et al. 2002; Katsuya, Ishikawa 
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et al. 2003; Tamaki, Nakamura et al. 2005; Wang, Zhu et al. 2006; Fava, Montagnana et al. 
2007; Franks 2008; Jiang, Sheng et al. 2008). In a review focusing on the effect of ADD1 on 
hypertension, Bianchi et al concluded that the impact of this gene variant was clear when 
context was taken into consideration (Bianchi, Ferrari et al. 2005). Joint effects of AGT, ACE 
and ADD1on hypertension have been reported (Barlassina, Schork et al. 2000; Staessen, 
Wang et al. 2001; Tamaki, Nakamura et al. 2005). For example, ACE DD homozygozity was 
associated with a 31% increase in the incidence of hypertension in a single gene analysis and 
with a 59% increase in carriers of the ADD1 Trp allele in 1461 randomly selected Caucasians 
(Staessen, Wang et al. 2001). The separate effects of ACE D homozygosity or ADD Trp 
homozygosity were not significant in a sample of 1647 Japanese but when these genotypes 
were combined (ACE DD and ADD TrpTrp), a significant association became apparent (OR: 
1.37 (1.03-1.82)) (Tamaki, Nakamura et al. 2005). As regards to AGT-ACE interaction, Kato 
et al did not find significant synergy for hypertension (Kato, Sugiyama et al. 2000).  
BMI and age are among the strongest predictors of hypertension and have been 
reported to modify the effects of gene variants. Adiposity positively correlates with the 
adipose AGT mRNA expression and may influence the expression of other RAS components 
(Van Harmelen, Ariapart et al. 2000). The ACE gene may be upregulated in obese 
individuals (Gorzelniak, Engeli et al. 2002). It may also be possible that effects of gene 
variants are stronger in individuals considered to be low risk for conventional factors such as 
BMI (i.e. <26 kg/m2) and age (i.e. <55 years) (Cambien, Costerousse et al. 1994). 
Unfortunately, studies examining potential effect measure modification by these factors have 
been lacking and results of the few studies conducted have not been consistent. Fava et al 
showed that among 6103 Swedes, age did not modify the effect of carrying the ADD1 
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460Trp allele but showed that its hypertensive effect were significant only in women 
belonging to the highest tertile of BMI (≥ 27 kg/m2). Zaman et al did not observe age 
modification in the effect of ACE I/D in a study involving 1340 Japanese (Zaman, Yoshiike 
et al. 2001). Yoshida et al, examining 263 Japanese reported that having at least one I allele 
was associated with hypertension in the elderly group (>70 years) but not in the middle aged 
group (30-60 years (Yoshida, Ishigami et al. 2000). On the contrary, Sugimoto et al observed 
that among 1490 Japanese, the effect of ADD1 Trp allele was significant only in younger 
subjects (< 60 yrs) with low plasma renin activity (Sugimoto, Hozawa et al. 2002).  
 
B.3. Sodium intake and hypertension 
Dietary sodium influences BP. Although not all authors agree, most deduce that 
“there is conclusive evidence that dietary salt is positively associated with BP” (Chobanian, 
Bakris et al. 2003; WHO 2007). Increased sodium intake can raise BP by increasing fluid 
volume and preload (extracellular volume expansion) and by mechanisms that are volume-
independent (i.e. increase sympathetic nervous system activity, angiotensin-mediated central 
nervous system effects) (Rodriguez-Iturbe, Romero et al. 2007).  
Numerous epidemiologic studies and clinical trials support the positive salt-BP 
relationship. The INTERSALT study, a cross-sectional study involving 32 countries with 
more than 10,000 respondents, showed a positive correlation between sodium excretion and 
BP: a 100 mEq difference in urinary sodium was associated with a 3-6 mmHg difference in 
systolic BP (INTERSALT 1988; Stamler, Rose et al. 1989).  Another population-based study 
of 24 communities confirmed this association (Law, Frost et al. 1991).   
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However, there is varying BP response to salt intake suggestive of salt-sensitivity. 
Most individuals consume high-sodium diets but not all of these individuals develop 
hypertension. This suggests the involvement of genetic factors and interactions with other 
exposures. For example, obesity has been found to increase the hypertensive effect of salt. 
The excretion of excess sodium is decreased in the presence of obesity, therefore elevation of 
BP is needed to excrete salt loads (Karppanen and Mervaala 2006).  However, a positive 
interaction of the effects of BMI and sodium intake on hypertension has not been consistently 
shown. In a study involving 60 obese and 18 non-obese adolescents, a change from a high 
salt to a low salt diet resulted to a larger mean change in mean arterial pressure (MAP) in the 
obese group suggesting salt sensitivity (Rocchini, Key et al. 1989). A 24-week, placebo-
controlled, two-period, crossover trial of sodium supplementation in 112 African Americans, 
aged 25 to 64 years, showed that variability-adjusted BP change correlated with BMI (Flack, 
Grimm et al. 2002). However, a double-blind randomized study of 46 White non-obese 
subjects aged 25 to 80 years showed that salt-sensitive subjects had lower body weight than 
salt-resistant individuals and that subjects with a BMI <26 kg/m2 showed a rise in MAP 
when moving from a low sodium to a high sodium diet, whereas subjects with BMI >26 
kg/m2 did not (Overlack, Ruppert et al. 1995).  
Older age is associated with increased sodium sensitivity, a steeper BP and 
exchangeable body sodium relationship, decreased gain of the baroreceptor reflex, reduced 
renal perfusion, and a compromised buffering effect of large arteries on systolic and diastolic 
pressure (Staessen, Wang et al. 2003).  Law et al analyzed published reports of BP and 
sodium intake (47000 people from 24 communities around the world) and found that a 
difference of 2300 mg/day was associated with an average difference in systolic BP that 
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ranged from 5 mmHg at age 15-19 to 10 mmHg at age 60-69 years (Law, Frost et al. 1991). 
The Dietary Approaches to Stop Hypertension (DASH)-sodium trial where participants were 
given 3 levels of sodium (1150, 2300, 3450 mg/2100 kcal) for 30 days while consuming the 
DASH diet or a more typical American diet showed that age had a strong and graded 
influence on the effect of sodium on BP: sodium intake reduction from 3450 to 2300mg/2100 
kcal and reduction from 2300 to 1150 mg/2100 kcal resulted in reduction of systolic BP by 
4.8 and 1.0 mmHg for 23 to 41 years, 5.9 and 1.8 mm Hg for 42 to 47 years, 7.5 and 4.3 mm 
Hg for 48 to 54 years, and 8.1 and 6.0 mm Hg for 55 to 76 years (Bray, Vollmer et al. 2004).  
Results of a recent dietary feeding (GenSalt) study in China with 1906 participants 
corroborated these findings (He, Gu et al. 2009).   
 
C. Summary and significance  
Developing countries and/or transitional countries experiencing rapid socio-economic 
changes with consequent changes in food environment and lifestyle are critical settings in 
studying the emergence of obesity and the development of CVD risk factors. However, large 
population-based longitudinal studies of sufficient detail and duration are largely lacking. 
Most developing country and/or Asian studies are cross-sectional and cannot establish 
temporality therefore weak in determining causality. We are not aware of any longitudinal 
study in developing and transitional countries that have the time depth and number of follow-
ups that the CLHNS has. Studies in developed countries, mostly from the US, fail to examine 
ethnic differences other than the usual classifications (i.e. African Americans versus Whites), 
neglecting the growing Asian population, including the Filipino American population that 
represents almost 20% of Asian Americans. Understanding factors that influence the 
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development of hypertension among Filipinos can potentially provide insights in narrowing 
health disparities in the US. Furthermore, research in developing and transitional countries 
such as the Philippines are essential in the context of global health, especially when the 
prevalence of obesity and CVDs are increasing in more and more resource-poor countries 
around the world.  The study may provide critical information necessary for the prevention 
efforts in these settings and potentially narrow global health disparities.  
Our study, using CLHNS data with genetic information, repeated anthropometric 
measures that span over 20 years, dietary sodium intake and recent BP measurements, offers 
a unique opportunity to address information gaps by improving our understanding of the 
effects of long-term exposures on hypertension and looking at gene-gene and gene-
environment interactions. To our knowledge, no other study with sufficient detail and 
duration has explored the interactions between gene, sodium intake and longitudinal 
measures of weight in predicting hypertension risk.
   
 
 
 
 
III. Overweight duration and incidence of hypertension in Filipino women 
 
A. Abstract  
Background: It is well known that excess weight increases the risk of hypertension. 
Less is known about whether the risk of hypertension differs in those who have recently 
become overweight (OW) from those who have been OW for a longer period. Methods and 
Results: We examined the effect of duration of OW (BMI>=25 kg/m2) independent of 
current BMI on the five-year (2002 to 2007) cumulative incidence of hypertension in a 
sample of 1607 women participants of the Cebu Longitudinal Health and Nutrition Survey. 
OW duration was determined by using repeatedly measured weight and height gathered from 
1983/84 to 2002. We identified 6 patterns representing OW history and duration: never OW 
(56.8%), not currently OW but had been OW (4.5%), OW < 4 years (9.1%), OW 4-10 years 
(13.1%), OW 11-17 years (12.5%), and OW ≥ 18 years (4.0%) with corresponding 5-year 
cumulative incidence of hypertension of 20.8%, 27.4%, 29.5%, 32.4%, 40.3% and 56.9%, 
respectively. After adjusting for 2002 age and BMI using poisson regression, we observed an 
increasing trend in the five-year cumulative incidence of hypertension according to OW 
history and duration. Compared to never OW women, the adjusted incidence ratio for 
hypertension was 1.40 (95% confidence interval (CI), 1.01-1.94) for women OW between 
11-17 years and 1.68 (95% CI: 1.09-2.59) for women OW for ≥ 18 years. Conclusions: 
Since OW duration regardless of current weight appear to increase hypertension incidence, 
efforts to prevent earlier weight gain should be stressed.  
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B. Introduction 
 Large shifts in obesity, hypertension, and many other non-communicable 
diseases are occurring across the globe (Kearney, Whelton et al. 2005; Popkin 2008).  The 
Philippines, a developing country with a population of over 88 million (NSO 2008), has not 
been immune from these changes.(Adair 2004; Mackay and Mensah 2004; FNRI 2006; DOH 
2007) Heart and vascular diseases are ranked first and second leading causes of death in the 
country accounting for 17% and 13% of deaths (in 2002), respectively (DOH 2007). 
Estimated disability adjusted life years lost per 1000 population from heart disease are higher 
in the Philippines than in the U.S. or China (Mackay and Mensah 2004). Overweight (OW) 
or obesity prevalence in the country has increased from 16.6% in 1993 to 24% in 2003 
(FNRI 2006). 
Adiposity measured through the body mass index (BMI) or abdominal fat patterning 
reflected by waist-hip ratio or waist circumference has been associated with increased blood 
pressure (BP) in both genders and across ethnicities (Must, Spadano et al. 1999; Brown, 
Higgins et al. 2000; Janssen, Katzmarzyk et al. 2002; Adair 2004; Davy and Hall 2004).  A 
Framingham Heart Study data suggested that 65-75% of the risk of hypertension can be 
attributed to excess weight (Garrison, Kannel et al. 1987).  Possible mechanisms involved in 
the excess weight-increased BP relationship include insulin resistance and hyperinsulinemia 
(Reaven, Lithell et al. 1996; Davy and Hall 2004), leptin resistance (Hall, Jones et al. 2003; 
Davy and Hall 2004; Berg and Scherer 2005; Mathew, Patel et al. 2007), activation of the 
sympathetic nervous and renin-angiotensin-aldosterone systems (Hall, Jones et al. 2003; 
Segura and Ruilope 2007), increased procoagulatory activity and endothelial dysfunction 
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(Berg and Scherer 2005; Shankar and Steinberg 2005), subclinical inflammation (Berg and 
Scherer 2005), and increased renal sodium re-absorption resulting in volume expansion 
(Hall, Jones et al. 2003; Wofford and Hall 2004; Mathew, Patel et al. 2007). 
However, less is known about whether the risk of hypertension differs in those who 
have recently become OW compared to those who have been OW for a longer period, 
especially among Asians who tend to develop hypertension at lower BMI thresholds (Colin 
Bell, Adair et al. 2002; Lear, Toma et al. 2003; Nguyen, Adair et al. 2008). Although OW 
duration has been associated with other obesity-related morbidities such as insulin resistance 
(Muscelli, Camastra et al. 1998; Janssen, Katzmarzyk et al. 2004), type 2 diabetes mellitus 
(Pontiroli and Galli 1998; Wannamethee and Shaper 1999; Sakurai 2000), and left 
ventricular muscle hypertrophy which can accompany increased BP (Nakajima, Fujioka et al. 
1985; Licata, Scaglione et al. 1992; Urbina, Gidding et al. 1995), few studies have 
investigated OW duration as a risk factor for hypertension. Results of studies examining the 
association between OW duration and hypertension were inconsistent: two studies found no 
association (Pontiroli and Galli 1998; Hekimsoy and Oktem 2003) while one found a positive 
association among women (Janssen, Katzmarzyk et al. 2004). Moreover, these studies were 
cross-sectional, and relied on recall of OW duration (Pontiroli and Galli 1998; Hekimsoy and 
Oktem 2003; Janssen, Katzmarzyk et al. 2004). The present study examined this relationship 
by using population-based longitudinal anthropometric data measured over a substantial 
proportion of adult life of Filipino women. Unlike previous studies, we used OW duration 
before the onset of hypertension as the exposure and 5-year cumulative incidence of 
hypertension (2002-2007) as the outcome to establish that the entire duration of excess 
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weight happened before the development of hypertension.  We hypothesized a positive 
relationship between OW history and incident hypertension, independent of 2002 BMI. 
 
C. Methods  
C.1. Data source and sample  
We used data from the ongoing Cebu Longitudinal Health and Nutrition Survey 
(CLHNS) (Adair and Popkin 2001). The CLHNS was conducted in Metropolitan Cebu, one 
of the metropolitan areas in the Philippines, with a population of over 2 million (NSO 2008). 
The study area is ecologically diverse, ranging from densely populated barangays 
(communities) in the cities, less dense peri-urban areas and rural towns, to the more isolated 
mountain and island rural areas. It is one of the most rapidly developing regions of the 
country.  In 1983, a stratified, single stage sampling design was used to randomly select 33 
barangays and all pregnant women in the selected barangays were initially invited to 
participate and were included in the survey if they gave birth between May 1983 and April 
1984 (n=3327). Subsequent surveys took place immediately after birth, then every 2 months 
for 24 months for all women with singleton, live births. Follow-up surveys were conducted in 
1991, 1994, 1998, 2002, 2005 and 2007. The sample for this study is limited to women who 
remained in the 2002 and 2007 surveys (n=1962).  In 2002, their ages ranged from 32 to 65 
years. We excluded women who were pregnant in either survey (n=30), those missing BP 
measurements (n=3) and those who were hypertensive in 2002 (n=322) leaving an analysis 
sample of 1607.  None had missing data on any of the 2002 survey anthropometric 
measurements and other covariates. 
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C.2. Analysis variables 
BP was measured using a mercury column sphygmomanometer after a 10 minute rest 
when the woman was seated. The mean of three measurements was used to represent systolic 
BP and diastolic BP. Hypertension was defined as systolic BP   ≥ 140 mmHg or diastolic BP 
≥ 90 mmHg (Chobanian, Bakris et al. 2003). Data on the use of anti-hypertensive 
medications was not available in the 2007 survey, therefore we did not include this in the 
definition to be consistent in both surveys. Analyses excluding women who reported taking 
anti-hypertensive medications in 2002 (n=45) yielded similar results. We calculated 5-year 
cumulative incidence by dividing new cases of hypertension occurring in the study interval 
2002-2007 by the total at risk population (non-hypertensive in 2002).  
Anthropometric measurements were taken at home by trained research personnel 
while participants were wearing light clothing. Weight was measured using portable scales to 
the nearest 0.1 kg while height was measured using portable stadiometers to the nearest 0.1 
cm. BMI was calculated as weight in kg divided by squared height in meters. For the first 
non-pregnant BMI, we used weight collected 4 months postpartum. About 76% of women 
had non-pregnant BMI for all survey rounds (from 1983/84 to 2002); only 3% had missing 
data in more than 1 survey. If non-pregnant BMI was missing, we imputed using the mean 
BMI of adjacent surveys. For each survey round (1983/84, 1991, 1994, 1998, 2002), we 
created a binary variable indicating whether the non-pregnant woman was OW (BMI ≥ 25 
kg/m2) (WHO 2000). These binary OW variables were examined for patterns over time and 
were used to group women into 6 OW duration categories. Women who were not OW in 
2002 were classified as: never OW or with OW history (had been OW in at least 1 survey). 
Women who were OW in 2002 were classified according to the number of consecutive 
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preceding surveys that they were OW and grouped as: < 4 yrs OW, 4-10 yrs OW, 11-17 yrs 
OW, and ≥ 18 yrs OW. Waist circumference was measured using standard measuring tapes 
and deemed high risk if ≥ 88 cm (WHO 2000). 
Community, household and individual level covariates were collected through in-
home face-to-face interviews using structured questionnaires. Age, occupational physical 
activity, smoking habits, alcohol consumption, income, education, reproductive history 
(number of pregnancies and menopausal status) and community urbanicity level at the time 
of the 2002 survey were examined as potential effect measure modifiers or confounders. 
Age, log of household income, education (number of years of formal schooling), and number 
of pregnancies were used as continuous variables. Indicator variables were created to 
represent levels of occupational physical activity (not working, sedentary, light, moderate, or 
heavy) based on detailed occupation code, posture at work and physical demands of jobs. 
Occupational physical activity is an important component of energy expenditure in 
developing countries such as the Philippines (Forrest, Bunker et al. 2001). Binary indicator 
variables were created for smoking status (current smoker or not), alcohol consumption 
(current drinker or not) and menopausal status (postmenopausal or not).  We used a 
continuous urbanicity index variable (0-70 scale) based on population size and density, 
community infrastructure, economic and environment characteristics. This index has been 
validated and found to be a better measure of urbanicity than the urban-rural dichotomy 
(Dahly and Adair 2007).  
We obtained informed consents from all participants. The study protocol was 
approved by the University of North Carolina Institutional Review Board for the Protection 
of Human Subjects.  
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C.3. Statistical analysis  
Differences in proportions and means of selected characteristics of women in 2002 
according to OW duration categories were compared using chi-square test and analysis of 
variance, respectively. Poisson regression with the robust error variance (Zou 2004) was used 
to estimate the effect of OW duration on hypertension risk. For the main exposure variable, 
we used indicator variable coding to represent the OW duration groups, with the never OW 
group as reference. Considering the well-known effect of BMI on BP, we purposely 
controlled for 2002 BMI (continuous) in the model to isolate the effect of OW duration. To 
determine which other covariates to retain in the final model, we evaluated each variable’s 
potential as an effect measure modifier and/or confounder. First, we assessed for effect 
measure modification by including interaction terms with OW duration in the model. We 
deemed the covariate as an effect measure modifier if the p-value of the interaction term 
(with OW duration) was < 0.10. We found no significant effect measure modifiers. Next, 
potential confounders were assessed based on the backward elimination, change-in-estimate 
approach (Rothman and Greenland 1998). If the exclusion of the covariate substantially (at 
least 10%) changed the exposure-outcome effect estimates, then the covariate was identified 
as a confounder. Only age was found to be a significant confounder. Thus, the final model 
controlled for BMI and age. We evaluated attrition bias by weighting the observations by the 
reciprocal of the probability of being in the study sample (Fitzgerald, Gottschalk et al. 1998). 
Since the weighted analysis was not substantially different from the un-weighted analysis, we 
present un-weighted results. STATA/SE version 10.1 was used in all analyses.  
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D. Results  
The largest difference in average age among the OW duration groups was < 4 years 
(Table 3.1). BP, BMI and waist circumference were positively associated with OW duration. 
Women who were not OW at any survey had the lowest systolic and diastolic BP, BMI and 
waist circumference while those who had been OW for ≥18 years had the highest values. 
Compared to women who were OW in 2002, those who were not OW were more likely to 
smoke and work in jobs requiring moderate to heavy exertion. Never OW women were the 
least educated. 
OW prevalence increased 9-fold, from 4.3% to 38.7% (Figure 3.1) from 1983/84 to 
2002. The greatest annual increase in OW prevalence occurred between the first three survey 
rounds. Almost all OW women in 1983/84 and about 88% of OW women in 1991 remained 
OW in succeeding surveys to 2002.        
Never OW women comprised 56.8% of the sample. Among OW women, the most 
frequent duration categories were 4-10 and 11-17 years. Five-year cumulative incidence (per 
100 persons at risk) of hypertension differs by OW duration group (Figure 3.2).  From 2002 
to 2007, 27.3% of women developed hypertension and crude analysis suggests hypertension 
incidence was positively associated with OW duration (p for trend <0.01). Cumulative 
incidence of hypertension for women OW for ≥18 years was 2.7 times more than that of the 
never OW women (56.9% and 20.8%, respectively).  
After adjusting for 2002 age and BMI using poisson regression, we still observed an 
increasing trend in the five-year risk of hypertension according to OW history and duration 
(Table 3.2). The average risk for hypertension among women who had been OW for more 
than 10 years was significantly higher than never OW women (reference). Specifically, 
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compared to never OW women, the adjusted incidence ratios (IR) for hypertension were 1.40 
(95% confidence interval (CI), 1.01-1.94) for women OW between 11-17 years and 1.68 
(95% CI: 1.09-2.59) for women OW for at least 18 years (Model 1).  
To underscore the importance of controlling for BMI when examining the association 
between duration of OW and hypertension incidence, we examined the effect estimates with 
BMI excluded from the model. Taking out 2002 BMI from the model substantially increased 
the cumulative IR for all OW duration categories when compared to the never OW women, 
especially that of the OW ≥ 18 years group where IR changed from 1.68 to 2.64 (Model 2 
versus Model 1).  In addition, inclusion of the binary waist circumference variable in the age- 
and BMI-adjusted model did not change the OW duration effect estimates (Model 3 versus 
Model 1).  
Using coefficients from our regression model, the likelihood of developing 
hypertension can be estimated under different scenarios, holding age constant. Compared to 
never OW women with a BMI of 23 kg/m2, women with a BMI of 26 kg/m2 who had been 
OW for <4 years were 36% more likely to develop hypertension, while women with a BMI 
of 25 kg/m2  who had been OW for at least 18 years were 83% more likely to develop 
hypertension.   
 
E. Discussion   
Excess weight is an established risk factor for hypertension but not all OW or obese 
individuals have high BP. This may be partly explained by the variations in the length of 
exposure to excess weight, a potentially important factor in the development of hypertension. 
As suggested, a constant elevation in body weight may be necessary for obesity-related 
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morbidities to develop (Janssen, Katzmarzyk et al. 2004). This study showed that duration of 
OW, independent of magnitude of BMI, increases the 5-year risk of developing hypertension 
among adult women in Cebu, Philippines. Women who had been OW for more than 10 years 
had significantly higher propensity to develop hypertension compared to women who had 
never been OW. Restricting the analysis to women who were OW in 2002, with the OW <4 
years group as reference, yielded similar pattern of results (data not shown).   
By showing the significant effect of OW duration independent of BMI, our study 
underscores the importance of controlling for exposure duration when examining the effect 
of OW/obesity or BMI on hypertension to prevent mixing of effects. For example, we 
showed that a longer OW duration increased risk of incident hypertension to a greater extent 
even at a lower initial BMI.  It is therefore useful to assess and separate the effects of current 
size from weight history.  
The biological mechanisms linking prolonged OW and hypertension have not been 
completely elucidated. Prolonged OW or obesity has been associated with ventricular 
hypertrophy possibly induced by long-standing volume overload (Nakajima, Fujioka et al. 
1985; Scaglione, Dichiara et al. 1992; Alpert, Lambert et al. 1995), insulin resistance and 
hyperinsulinemia (Muscelli, Camastra et al. 1998; Janssen, Katzmarzyk et al. 2004), and 
gradual loss of kidney function that worsens with time (Wofford and Hall 2004). These 
abnormalities in turn may affect BP (Reaven, Lithell et al. 1996; Hall, Jones et al. 2003; 
Wofford and Hall 2004).   
To our knowledge, only three studies have looked at the association of OW/obesity 
duration with hypertension and their results are inconsistent (Pontiroli and Galli 1998; 
Hekimsoy and Oktem 2003; Janssen, Katzmarzyk et al. 2004). The earliest studies did not 
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observe a significant association between obesity duration and hypertension (Pontiroli and 
Galli 1998; Hekimsoy and Oktem 2003). Examining 200 Turkish women presenting at a 
clinic because of obesity (mean BMI 38.4 ± 6.1 kg/m2), Hekimsoy and Oktem did not find 
the degree, distribution and duration of obesity to be associated with hypertension (Hekimsoy 
and Oktem 2003). An Italian study of 760 patients (560 women) admitted for obesity-related 
health problems (mean BMI 36.1 ± 6.1 kg/m2) found that having hypertension is related to 
the degree but not the duration of obesity (Pontiroli and Galli 1998). Our findings are in line 
with a US study involving a representative sample of 2285 men and 2589 women 30-64 
years of age participating in NHANES III (Janssen, Katzmarzyk et al. 2004).  After 
controlling for BMI, the odds of having hypertension were 1.97 times higher among women 
who were OW ≥ 10 years compared to normal weight women; these results were not 
observed in men. Janssen et al. excluded underweight (BMI < 18.5 kg/m2) individuals from 
their sample. Doing the same in our study strengthened the influence of OW duration on 
hypertension risk – cumulative IR for OW 11-17 yrs and for OW ≥ 18 yrs increased to 1.49 
and 1.86, respectively. 
Our differing results may be partly attributed to differences in methods. First, our 
study is population-based and included all women regardless of BMI while the Turkish and 
Italian studies were clinic-based and limited to obese patients who had relatively high levels 
of obesity-related metabolic problems including hypertension. For example, 48% of the 
Turkish sample and 74% of the Italian sample were hypertensive. By design, none of our 
sample women were hypertensive in 2002 and about 27% were hypertensive by 2007. 
Second, we used different BP cutpoints in defining hypertension. Hekimsoy and Oktem 
defined hypertension as BP >135/85 mmHg or being treated for hypertension (including non-
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drug treatments such as weight loss), Pontirolli and Galli defined hypertension as BP 
>160/95 mmHg or taking hypotensive drugs, while our study and that of Janssen et al used 
the latest recommended cutpoint of BP ≥140/90 mmHg. We calculated duration from the 
time the woman first had a BMI of at least 25 kg/m2 while the first two studies assessed time 
since BMI ≥30 kg/m2.  Also, different duration categories were used.  
The present study has a number of unique dimensions, including the use of incident 
hypertension and repeatedly measured weight and height (using the same protocol). With the 
use of prospective longitudinal data, we were able to ensure that the entire duration of OW 
occurred before the development of hypertension. This allows us to better establish 
temporality and infer causality compared to previous studies which were all cross-sectional. 
Our use of measured weight and height collected over two decades of adult life reduces 
measurement error. The previous studies relied on recall, some dating as far back as > 20-30 
years. Using self-reported or recalled weight may bias effect estimates since recalled weight 
is not independent of BMI status, especially for OW/obese women who are more likely to 
underestimate their weight (Perry, Byers et al. 1995; Nyholm, Gullberg et al. 2007; Shields, 
Gorber et al. 2008).   
Our study has certain limitations. The CLHNS did not continuously monitor the 
sample women but collected data at certain intervals. We were not able to ascertain the exact 
time when the women became OW and developed hypertension. As with any prospective 
study with long follow-up duration, there is sample attrition. Further, to model five-year 
cumulative incidence of hypertension, we only included women who were not hypertensive 
in 2002 and were followed-up in 2007. The reduction in sample size may produce bias and 
limit the generalizability of results. Compared to women who are not in the sample, the 
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women included in this study had lower baseline BMI (mean BMI: 21.0 vs. 20.4 kg/m2 (t test 
p<.05), respectively) but similar age (mean age: 26.7 vs. 26.4 years (t test p>.05), 
respectively). BMI is positively associated with OW duration therefore we can posit that 
women who were excluded from the survey are more likely to have been OW for longer 
duration and to develop hypertension. For example, compared to the sample women, those 
who were excluded because they were hypertensive in 2002 had higher baseline BMI and 
were more likely to have been OW for more than 10 years. Thus, the OW duration-
hypertension relationship observed in the study sample is likely attenuated. Finally, results of 
analyses weighted by the reciprocal of the probability of being in the study sample were not 
considerably different from those of un-weighted analyses indicating no significant attrition 
bias. 
Using Philippine data allows us to make important contributions. This is a pioneering 
study on the effect of long term OW on BP involving an Asian population.  Asians are of 
special concern because they have the most rapid increases in obesity and obesity-related 
diseases worldwide (Popkin, Horton et al. 2001; Mendez, Monteiro et al. 2005) and they tend 
to develop CVD risk factors at lower BMI thresholds (Colin Bell, Adair et al. 2002; Lear, 
Toma et al. 2003; Nguyen, Adair et al. 2008). Also, this fills a gap in literature by focusing 
on a population of a developing country that is undergoing the earlier phases of the nutrition 
transition. It is in developing countries that we find alarmingly increasing rates of obesity and 
chronic diseases (WHO 2002; Lawes, Vander Hoorn et al. 2008).  Lastly, we add to CVD-
related studies focusing on women, a segment of the population who entail special CVD 
prevention guidelines (Mackay and Mensah 2004; Mosca, Banka et al. 2007). As the Janssen 
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et al. study indicated, OW duration seems an important factor in having hypertension in 
women but not in men (Janssen, Katzmarzyk et al. 2004). 
In summary, this study suggests that OW duration, independent of the degree of 
excess weight, increases the risk of developing hypertension in women. OW prevention 
efforts earlier in life should be stressed, especially since women who become OW tend to 
remain OW.      
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Table 3.1. Characteristics of non-pregnant, non-hypertensive Cebu women in the 2002 
survey, by overweight (OW) duration* 
 
 
Characteristics 
Never  
OW 
n = 912 
OW 
History† 
n = 73 
OW  
< 4 y 
n = 146 
OW   
4-10 y 
n = 210 
OW  
11-17 y 
n = 201 
OW   
≥18 y 
n = 65 
 
p-
value 
Age, y 45.5±0.2 47.2±0.7 43.7±0.4 44.2±0.4 45.3±0.4 47.4±0.6 <0.01 
Systolic BP, mmHg 105.6±0.4 110.7±1.2 109.0±1.0 110.4±0.7 114.1±0.7 118.1±1.4 <0.01 
Diastolic BP, mmHg 70.3±0.3 73.8±1.0 73.6±0.7 74.7±0.5 76.9±0.5 77.9±0.9 <0.01 
BMI, kg/m2 21.3±0.1 23.8±0.1 26.2±0.1 27.6±0.1 29.1±0.2 31.6±0.5 <0.01 
Waist, cm 71.9±0.2 78.1±0.5 82.4±0.4 85.1±0.4 88.5±0.5 92.2±1.1 <0.01 
Education, y 6.8±0.1 7.9±0.4 7.2±0.3 7.8±0.2 7.6±0.3 9.0±0.5 <0.01 
Smoker, % 19.2 20.5 7.0 12.4 10.4 20.0 <0.01 
Alcohol Drinker, % 39.3 43.8 45.5 41.4 37.8 38.5 0.70 
Occupational PA, %        <0.01 
     Not working 14.4 15.1 13.3 15.7 17.9 15.4  
     Sedentary 6.6 4.1 7.0 6.2 7.5 9.2  
     Light 46.9 54.8 53.8 59.0 56.7 61.5  
     Moderate 21.6 19.2 17.5 13.3 11.4 10.8  
     Heavy 10.5 6.8 8.4 5.7 6.5 3.1  
*
 Values are means ± standard error or percentages. † Women were not OW in 2002 survey but had been OW 
for at least 1 survey. y = year, BP = blood pressure, BMI = body mass index, and PA = physical activity. ‡ P-
values for analysis of variance for means and chi-square test for proportions. 
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TABLE 3.2. Cumulative incidence ratios (95% CI) for hypertension according to overweight 
(OW) duration in adult Cebu women, 2002-2007 
 Model 1* Model 2† Model 3‡ 
Never OW 1.00 (reference) 1.00 (reference) 1.00 (reference) 
OW history§ 1.14 (0.77-1.70) 1.27 (0.86-1.87) 1.13 (0.76-1.69) 
OW < 4 y 1.20 (0.87-1.65) 1.47 (1.11-1.95) 1.19 (0.86-1.64) 
OW 4-10 y 1.23 (0.90-1.67) 1.60 (1.27-2.02) 1.22 (0.90-1.67) 
OW 11-17 y 1.40 (1.01-1.94) 1.95 (1.58-2.40) 1.40 (1.01-1.95) 
OW ≥ 18 y 1.68 (1.09-2.59) 2.64 (2.06-3.38) 1.69 (1.10-2.60) 
*
 Adjusted for age and body mass index. † Adjusted for age. ‡ Adjusted for age, body mass index and waist 
circumference. § Women were not OW in 2002 survey but have been OW for at least 1 survey. 
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Figure 3.1. Trend in overweight (OW) prevalence from 1983/84 to 2002 among Cebu women 
who were not hypertensive in 2002. Values in gray area represent the percent of women who 
remained OW to 2002.  
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Figure 3.2. Percent distribution of Cebu women by overweight (OW) duration in the 2002 
survey (gray bars) and corresponding five-year cumulative incidence (per 100 persons at 
risk) of hypertension for each OW duration group (dots with error bars representing 95 
percent confidence interval). Hypertension cumulative incidence rate P for trend <0.01. 
*Women were not OW in 2002 survey but had been OW in at least 1 survey. y = years.
Hypertension 5-y cumulative incidence   
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IV. Effects of ACE and ADD1 variants on the prevalence of hypertension in Filipino 
women are modified by age 
 
A. Abstract   
Objective: To examine whether effects of the angiotensinogen (AGT) Met235Thr, 
angiotensin converting enzyme (ACE) intron 16 insertion/deletion (I/D) and alpha adducin 
(ADD1) Gly460Trp gene variants on hypertension prevalence in Filipino women are 
modified by age, BMI and presence of the other gene variants. Methods and Results:  We 
used data from 1776 participants (age 35-68 years) of the Cebu Longitudinal Health and 
Nutrition Survey in 2005. We measured blood pressure, weight and height and genotyped 
AGT Met235Thr, ADD1 Gly460Trp and rs4331 as a proxy for the ACE I/D variant. General, 
dominant, and recessive genetic models were explored. AGT Met235Thr influenced 
hypertension risk in all women. Adjusted OR (95% CI) comparing 1700 women carrying the 
Thr allele to 51 women homozygous for the Met allele was 2.57 (1.20-5.53). Evidence for 
association between ACE I/D and ADD1 Gly460Trp and hypertension was only observed 
considering modification by age. For each year increase in age, the adjusted OR for the 
effects of ACE II (versus DD/DI) and ADD1 GlyTrp/TrpTrp (versus GlyGly) increased by 
6% and 4%, respectively. For women aged ≥ 55 years, OR for ACE II (versus DD/DI) was 
2.53 (1.43-4.45) and OR for ADD1 GlyTrp/TrpTrp (versus GlyGly) was 1.83 (1.02-3.27). 
Corresponding ORs for younger women were not significant. No significant gene-gene and 
gene-BMI interactions were observed. Conclusions: The AGT Met235Thr polymorphism 
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may play an important role in the development of hypertension in Filipino women. There is 
also some evidence that ACE I/D and ADD1 Gly460Trp may contribute to hypertension risk 
in older women.   
 
B. Introduction   
Among the known cardiovascular disease (CVD) risk factors, hypertension makes the 
largest contribution to CVD burden, accounting for about 8 million of the estimated 16.7 
million CVD-related deaths per year (WHO 2002; Mackay and Mensah 2004). 
Approximately 80% of this burden is borne by low- and middle- income countries (Lawes, 
Vander Hoorn et al. 2008). In the Philippines, a country with a population of over 88 million, 
heart and vascular diseases are the first and second leading causes of death accounting for 
17% and 13% of deaths, respectively (DOH 2007).  
Hypertension is a complex multifactorial polygenic disease (Pausova, Tremblay et al. 
1999). Heritability estimates across studies and populations suggest that ~30% of the 
population variability in blood pressure (BP) may be attributed to genetic factors (Ward 
1995; Arnett, Baird et al. 2007). Candidate gene studies have shown evidence for association 
between specific genes and hypertension, albeit inconsistently (Arnett, Baird et al. 2007). 
The scientific statement of the American Heart Association Council assessing the relevance 
of genetics and genomics for the prevention and treatment of CVD listed at least 30 
candidate genes implicated in high BP and/or essential hypertension (Arnett, Baird et al. 
2007). However, none of these candidate genes showed significant evidence (p-value <  5 X 
10-7) in recent genome wide association studies of hypertension (Levy, Larson et al. 2007; 
WellcomeTrust 2007). 
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The renin-angiotensin system (RAS) is known to regulate BP by influencing vascular 
volume homeostasis and tone (Lifton, Gharavi et al. 2001). Thus, considerable efforts have 
been made in investigating polymorphisms in genes encoding the main components of this 
system. Of the angiotensinogen (AGT) gene polymorphisms, the Met235Thr polymorphism 
has been one of the most widely examined (Binder 2007) and has shown possible effect 
differences between populations. For example, a meta-analysis of 25055 individuals from 40 
studies showed that hypertension risk is increased by 29 and 60% in Asians and by 8 and 
19% in White subjects (MetThr versus MetMet and ThrThr versus MetMet, respectively). No 
significant increase was observed in Black subjects (Sethi, Nordestgaard et al. 2003).  The 
insertion/deletion (I/D) polymorphism in intron 16 of the angiotensin converting enzyme 
(ACE) gene has also been suggested in the pathophysiology of hypertension, with the D 
allele associated with higher ACE levels and endothelial dysfunction and therefore increased 
BP (Luft 2004; Penesova, Cizmarova et al. 2006). However, there have been inconsistent 
results regarding the association between these RAS polymorphisms and hypertension, with 
some studies showing significant associations (O'Donnell, Lindpaintner et al. 1998; Higaki, 
Baba et al. 2000; Sethi, Nordestgaard et al. 2003) and other studies showing no significant 
associations (Kato, Sugiyama et al. 2000; Sato, Katsuya et al. 2000; Matsubara, Suzuki et al. 
2002).  
One of the plausible explanations for the conflicting results is that the risk conveyed 
by genes in the development of hypertension is context-dependent (Franks 2008). For 
example, effects of both the ACE I/D and AGT Met235Thr polymorphisms on BP may be 
modified by the Gly460Trp variant of the alpha adducin gene (ADD1), a polymorphism that 
impacts BP primarily by enhancing tubular sodium re-absorption through increased cellular 
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expression and activity of the Na-K pump (Bianchi 2005; Bianchi, Ferrari et al. 2005). 
Barlassina (2000) showed that the ACE and ADD1 gene variants may act synergistically to 
increase BP and affect the pressure-natriuresis relationship where the large pressor effect of 
the ACE D allele was only seen in the presence of the ADD1 460Trp allele (Barlassina, 
Schork et al. 2000). Similarly, a study of Japanese individuals showed that AGT 235Thr and 
ADD1 460Trp did not increase hypertension odds when analyzed separately but were 
associated with hypertension when AGT ThrThr and ADD1 TrpTrp were combined (Tamaki, 
Nakamura et al. 2005). In addition, factors including gender, age, body mass index (BMI), 
diet, and physical activity have been suggested to modify the effects of candidate genes 
(Svetkey, Moore et al. 2001; Katsuya, Ishikawa et al. 2003; Wang, Zhu et al. 2006; Fava, 
Montagnana et al. 2007; Franks 2008; Norat, Bowman et al. 2008). For example, a Swedish 
study found that the ADD1 460Trp variant was associated with higher systolic and diastolic 
BP only in women belonging to the highest tertile of BMI (Fava, Montagnana et al. 2007).  
 This study aimed to examine the effects of AGT Met235Thr, ACE I/D and ADD1 
Gly460Trp polymorphisms on the risk of hypertension in Filipino women and explored the 
effects of these three polymorphisms in different genetic and environmental contexts by 
looking at potential gene-age, gene-BMI and gene-gene interactions. Few studies have 
looked at the effects of genetic polymorphisms on hypertension in developing countries, and 
fewer have examined potential effect measure modifications. Although there have been 
studies examining these genes among Asians (mostly Japanese and Chinese), results have not 
been consistent (Kato, Sugiyama et al. 2000; Sato, Katsuya et al. 2000; Ju, Zhang et al. 2003; 
Cha, Kim et al. 2007; Huang, Sun et al. 2007). This is the first study investigating the effects 
of genetic variants on the development of hypertension in Filipinos.  
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C. Methods 
C.1. Data source and sample  
The study sample is comprised of participants in the ongoing Cebu Longitudinal 
Health and Nutrition Survey (CLHNS). Details of the CLHNS study design have been 
described previously (Adair and Popkin 2001). Briefly, the CLHNS was conducted in 
Metropolitan Cebu, one of the main metropolitan areas in the Philippines. In 1983, a 
stratified, single stage sampling design was used to randomly select 33 barangays (villages in 
rural areas, neighborhoods in urban areas) and all pregnant women in the selected barangays 
were initially invited to participate.  Women were included in the survey if they gave birth 
between May 1, 1983 and April 30, 1984 (n=3327). Subsequent surveys took place 
immediately after birth, then every 2 months for 24 months for all women with singleton, 
live births. Follow-up surveys were conducted in 1991, 1994, 1998, 2002, 2005 and 2007.  
For this study, the sample is limited to 1789 women who provided a blood sample in 
the 2005 survey, who had information on at least one of the polymorphisms, and who did not 
have an apparent first degree relative in the study based on predicted identity by descent 
estimates from 95,000 SNPs using PLINK (http://pngu.mgh.harvard.edu/purcell/plink/) (data 
not shown) (Purcell, Neale et al. 2007) . We excluded women who were pregnant (n=8) and 
those missing BP measurements (n=5) for an analysis sample size of 1776.   
 
C.2. Analysis variables 
We used data taken during the 2005 survey, except for overweight (OW) duration. BP 
was measured using a mercury column sphygmomanometer after a 10 minute rest when the 
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woman was seated. The mean of three measurements was used to represent systolic BP and 
diastolic BP. Women reported all medications they were taking which were then classified 
according to their uses by a registered nurse. Hypertension was defined as systolic BP   ≥ 140 
mm Hg or diastolic BP ≥ 90 mm Hg or taking anti-hypertensive medications (Chobanian, 
Bakris et al. 2003).  
Anthropometric measurements were taken at home while participants were wearing 
light clothing. Weight was measured using portable scales while height and waist 
circumference were measured using portable stadiometers and standard measuring tapes, 
respectively. BMI was calculated as weight in kg divided by squared height in meters. To 
determine OW duration, we created a binary variable indicating whether the non-pregnant 
woman was OW (BMI ≥ 25 kg/m2) (WHO 2000) for each survey round from baseline to 
2005. These binary OW variables were examined for patterns over time and were used to 
group women into five OW duration categories – never OW, with OW history (not OW in 
2005 but have been OW in at least 1 survey), OW < 3 yrs, OW 3-10 yrs, and > 10 yrs OW, as 
determined by the timing of CLHNS surveys.  Indicator variables were used to represent 
each OW duration category. Waist circumference was deemed high risk if ≥ 88 cm (WHO 
2000). 
Other variables of interest were collected by trained personnel through in-home face-
to-face interviews using structured questionnaires. Age (years), log of household income, 
education (number of years of formal schooling), and number of pregnancies were used as 
continuous variables. Indicator variables were created to represent levels of occupational 
physical activity (not working, sedentary, light, moderate, or heavy) based on detailed 
occupation code, posture at work and physical demands of jobs. Binary indicator variables 
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were created for smoking status (current smoker or not), alcohol consumption (current 
drinker or not) and menopausal status (postmenopausal or not).   
 
C.3. Genotyping  
We selected three genetic polymorphisms suggested to be implicated in the 
development of high BP or essential hypertension (Jeunemaitre, Soubrier et al. 1992; Niu, 
Chen et al. 2002; Bianchi, Ferrari et al. 2005; Arnett, Baird et al. 2007) and shown to have 
minor allele frequency of >0.01 in Asian populations (Higaki, Baba et al. 2000; Ju, Zhang et 
al. 2003; Tamaki, Nakamura et al. 2005; Cha, Kim et al. 2007).  These included the 
Met235Thr polymorphism of AGT (rs699, Met=T, Thr=C), Gly460Trp polymorphism of 
ADD1 (rs4961, Gly=G, Trp=T), and I/D polymorphism of ACE represented by rs4331 (G/A 
alleles). Variant rs4331 was reported to be in linkage disequilibrium (D’=1.000, r2 =0.967) 
with ACE I/D among 511 Japanese and can be more conveniently genotyped than the latter 
(Rieder, Taylor et al. 1999; Tanaka, Kamide et al. 2003). DNA was isolated from blood using 
the Gentra Puregene protocol and genotyping was performed using TaqMan allelic 
discrimination assays (Applied Biosystems, Foster City, CA). Genotype distributions of the 
three polymorphisms were consistent with Hardy-Weinberg equilibrium, with Pearson chi-
square test p-values >0.05.  
We obtained informed consents from all participants. The study protocol was 
approved by the University of North Carolina Institutional Review Board for the Protection 
of Human Subjects.  
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C.4. Statistical analysis  
Differences in proportions and means of selected characteristics of women in 2005 
according to genotype were compared using chi-square test and t-test, respectively. To 
estimate the association between the genetic variants and hypertension, we used logistic 
regression. Since the modes of inheritance of the selected polymorphisms have not been 
completely elucidated, we initially tested the general or co-dominant model with no 
assumption of mode of inheritance. Based on the apparent direction of effects observed in the 
results of the general models, the dominant, recessive or additive genetic modes of 
inheritance were selected for further exploratory analysis and only significant results are 
reported. We assessed effect measure modification using likelihood ratio (LR) test where we 
compared models with and without interaction terms (i.e. gene*age or gene*BMI or 
gene*gene). Significant effect measure modification was set at LR test chi-square p-value 
<0.10.  Higher alpha was specified because homogeneity tests have lower power to detect 
differences (Rothman and Greenland 1998). For the effect of the polymorphism on 
hypertension to be considered significant, alpha was set at p-value <0.05. We did not adjust 
for the multiple tests of SNPs, models of inheritance and number of interactions, thus results 
may be considered nominal p-values. Aside from age and BMI, we controlled for waist 
circumference, OW duration, cigarette smoking, alcohol consumption, menopausal status, 
years of education, and log of household income. Additionally adjusting for other covariates 
did not change the magnitude or precision of the estimates. We evaluated attrition bias by 
weighting the observations by the reciprocal of the probability of being in the study sample 
(Fitzgerald, Gottschalk et al. 1998). Since the weighted analysis was not substantially 
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different from the un-weighted analysis, we present un-weighted results. STATA/SE version 
10.1 (StataCorp, College Station, TX) was used in all analyses. 
 
D. Results  
In 2005, participants’ age ranged from 35 to 68 years. Women had an average BMI of 
24.3 kg/m2, and about 42% were OW. Most OW women had been OW for more than 10 
years. About 28% were hypertensive (Table 4.1).  
Gene-age, gene-BMI and gene-gene interactions were evaluated for the three 
polymorphisms. The AGT Met235Thr polymorphism appeared to be the strongest predictor 
of hypertension status, with homogenous effects across women with varying age, BMI, and 
ACE or ADD1 genotypes. The hypertension odds among 1700 women carrying one or more 
copies of the 235Thr allele were 2.57 times (95% CI: 1.2-5.53; p-value = 0.016) higher than 
that of 51 women with the MetMet genotype (Table 4.2). No significant gene-BMI or gene-
gene interactions were observed for any of the three polymorphisms. 
For the effects of ACE and ADD1 polymorphisms, we found age to be a significant 
effect measure modifier. Figure 4.1 (A) shows that the estimated odds ratio (OR) for 
hypertension comparing 633 women homozygous for ACE II to 1054 women with ACE 
DD/ID (reference) genotypes increased with age. For each year increase in age, the OR for 
the effect of ACE II increased by about 6% (LR test p = 0.006).  For example, using 
coefficients from the logistic regression model, the estimated OR (95% CI) for hypertension 
comparing women with ACE II to women carrying one or more copies of the D allele was 
0.69 (0.45-1.06; p-value = 0.089) for 40 year old women but was 2.04 (1.27-3.29; p-value = 
0.003) for 60 year old women. We found a similar age modification pattern for the effect of 
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ADD1 on hypertension (LR test p = 0.079); however the observed gene effects were weaker 
(Figure 4.1 (B)). For each year increase in age, the OR for hypertension associated with 
ADD1 460Trp increased by about 4% (p for interaction = 0.079). Examining the effect of age 
on hypertension using spline analysis (not considering genotype), we observed that the effect 
of age changed at around 55 years. We stratified women into two age groups according to 
this cut-point and observed the odds of having hypertension among 89 women >=55 years 
with the ACE II genotype were 2.53 times higher (1.43-4.45; p-value = 0.001) compared to 
171 women carrying the D allele (Table 2). For ADD1, 184 older women with the 460Trp 
allele had higher odds (OR: 1.83, 95% CI: 1.02-3.27; p-value = 0.041) of hypertension 
compared to 83 Gly homozygotes.  
 
E. Discussion  
 Owing to the known influence of the RAS in potentially all aspects of BP regulation, 
genes in this system are among the most probable and likely have been the most investigated 
candidates in the quest to unravel the genetics of hypertension (Lifton, Gharavi et al. 2001; 
Luft 2004; Binder 2007). The current study found that AGT Met235Thr polymorphism was 
associated with the prevalence of hypertension in Filipino women using a model dominant 
for the common Thr allele. The odds of hypertension were doubled among women with the 
235Thr allele. We also observed increased hypertension odds among older women with the 
ACE II genotype using a model recessive for the common I allele. In addition to looking at 
RAS genes, the current study examined the potential hypertensive effect of the Gly460Trp 
polymorphism of the ADD1 gene. We did not find strong evidence supporting this 
association but the polymorphism may be a contributing factor in the pathophysiology of 
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hypertension in older women. Gene-BMI and gene-gene interactions were not observed in 
this study.  
 Jeunemaitre et al were the first to suggest the role of the AGT Met235Thr 
polymorphism in the development of hypertension (Jeunemaitre, Soubrier et al. 1992). Using 
data from 267 men and women of Northern and Western European descent, they showed that 
the ThrThr genotype was associated with an increase in plasma angiotensinogen and a 95% 
increase in the odds of hypertension compared to the MetMet genotype. Increased BP may be 
explained by the role of AGT in encoding the precursor molecule for angiotensin II which 
causes intense vasoconstriction and sodium re-absorption in the kidney. However, results of 
the numerous studies that followed this pioneering work were not consistent. A case-control 
study involving 1476 subjects reported a null association between Met235Thr and 
hypertension (Kato, Sugiyama et al. 2000) but a meta-analyses involving 25055 individuals 
concluded that AGT Met235Thr was associated with increased risk of hypertension in white 
subjects (OR: MetThr 1.08, ThrThr 1.19) and Asians (OR: MetThr 1.29, ThrThr 1.60); 
Asians were represented by 8 Japanese, 3 Chinese and 1 Emirati studies totaling 5181 
individuals (Sethi, Nordestgaard et al. 2003).  Results of our study support the findings of 
latter meta-analysis, showing similar or potentially higher ORs (MetThr 2.53 (1.15-5.56), 
ThrThr 2.57 (1.19-5.55)) for Filipino women.  
The D allele of the ACE I/D polymorphism has been linked to higher plasma ACE 
levels (Tiret, Rigat et al. 1992; Luft 2004) and endothelial dysfunction (Penesova, Cizmarova 
et al. 2006) providing possible explanations for its role in increased BP. This variant has been 
reported as one of the most consistently linked polymorphisms to CVD in the general 
population but evidence of association with hypertension has been less convincing (Niu, 
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Chen et al. 2002; Luft 2004). ACE DD has been shown to influence hypertension risk with 
possible gender-specific effects (O'Donnell, Lindpaintner et al. 1998; Higaki, Baba et al. 
2000; Lynch, Arnett et al. 2007). For example, using a population-based sample of mostly 
Caucasian men and women (Framingham Study), O’Donnell et al reported adjusted ORs for 
hypertension in 1445 men for the DD and DI genotypes as 1.59 (1.13-2.23) and 1.18 (0.87-
1.62), respectively, versus II (O'Donnell, Lindpaintner et al. 1998). The corresponding ORs 
in 1650 women were 1.00 (0.70-1.44) and 0.78 (0.56-1.09), respectively. Similarly, Higaki et 
al analyzing data from a Japanese sample of 2340 men and 2674 women (Suita Study) 
reported an estimated OR (DD vs II) of 1.75 (1.21-2.53) for men and an OR of 1.17 (0.79-
1.72) for women (Higaki, Baba et al. 2000). When stratified by age (≤60, >60 years) they 
found that the influence of the DD genotype was stronger in the younger age groups and 
weakest for older women. Zaman et al did not observe age modification in the effect of ACE 
I/D in a study involving 1340 Japanese (Zaman, Yoshiike et al. 2001). Our study found age 
as a potentially significant effect measure modifier of the relationship between the ACE I/D 
variant and the prevalence of hypertension, where we found significant association only in 
older women (≥ 55 years). Also, we found an opposite effect of the D allele in the older 
group – older women with the II genotype had increased risk of hypertension compared to 
women carrying at least one copy of the D allele. However, this pattern is not unique to our 
sample. Yoshida et al, examining 263 Japanese reported that having at least one I allele was 
associated with hypertension in the elderly group (>70 years) but not in the middle aged 
group (30-60 years) (Yoshida, Ishigami et al. 2000). A potential mechanism may be the 
higher aortic arterial stiffness observed in II genotypes (versus ID/DD) that has been 
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observed in different populations (Benetos, Gautier et al. 1996; Taniwaki, Kawagishi et al. 
1999; Dima, Vlachopoulos et al. 2008).   
The ADD1 Gly460Trp variant may cause hypertension by enhancing tubular sodium 
re-absorption in the kidney (Bianchi 2005; Bianchi, Ferrari et al. 2005). The relationship 
between ADD1 Gly460Trp polymorphism and hypertension in humans was first 
demonstrated by Cusi et al (Cusi, Barlassina et al. 1997). As with the other polymorphisms, 
results of studies that followed were inconsistent. For example, among Asians, Kato et al did 
not find a significant association between the 460Trp allele and hypertension in 507 Japanese 
(Kato, Sugiyama et al. 1998), Shin et al corroborated the negative finding examining 903 
Koreans (Shin, Chung et al. 2004), but Huang et al found a significant association (OR: 1.43, 
p = 0.029) among 751 Han Chinese (Huang, Sun et al. 2007). Our study found a nominally 
significant association between the 460Trp allele and hypertension in older women only. On 
the contrary, Sugimoto et al observed that among 1490 Japanese, the effect of ADD1 Trp 
allele was significant only in younger subjects (< 60 yrs) with low plasma renin activity 
(Sugimoto, Hozawa et al. 2002). Among 6103 Swedes, age did not modify the effect of 
ADD1 460Trp allele (Fava, Montagnana et al. 2007).  
Results of this study should be interpreted with caution. First, the reduction in sample 
size from baseline (1983/84) to 2005 may produce bias and limit the generalizability of 
results. Compared to women who were not in the sample, the women included in this study 
had lower baseline BMI (20.8 versus 20.6 kg/m2), were older (age at baseline: 26.3 versus 
26.8 years) and had less years of education (8.0 versus 7.2 years). However, the main reason 
for attrition was out-migration (moving outside Metropolitan Cebu) and it is unlikely that this 
was associated with hypertension status and genotype distribution. Results of analyses 
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weighted by the reciprocal of the probability of being in the study sample were not 
considerably different from those of un-weighted analyses indicating no significant attrition 
bias. Second, the 3 BP measurements that were averaged to represent BP were taken on the 
same day and cannot account for day to day variations. This may cause regression dilution 
and result in attenuated results (Rothman and Greenland 1998). Third, different allele 
frequencies and levels of environmental exposures may make it difficult to compare and 
transfer the results of one study population to another. We typically observe allele 
frequencies in this Cebu sample to be similar to Han Chinese and Japanese samples 
(Marvelle, Lange et al. 2007). The frequencies of the higher risk AGT Thr allele (84%) and 
ADD1 Trp allele (43%) in our sample are similar to those reported in other East Asians (~68-
83% and ~42-66%, respectively) (Kato, Sugiyama et al. 2000; Katsuya, Ishikawa et al. 2003; 
Sethi, Nordestgaard et al. 2003) and higher than reported in Caucasians (~43-44% and ~18-
27%, respectively) (Sethi, Nordestgaard et al. 2003; Bianchi 2005; Goldenberg, Moss et al. 
2006). Likewise, the frequency of the ACE II genotype in our sample (37%) is similar to 
other East Asians (~37-43%) (Zaman, Yoshiike et al. 2001; Jiang, Sheng et al. 2008) and 
higher than reported in Caucasians (~17-23%) (Staessen, Wang et al. 2001; Dima, 
Vlachopoulos et al. 2008). Considering potential age-dependent effects of the ACE I/D and 
ADD1 Gly460Trp polymorphisms, the different age distributions and categorizations of 
participants across studies may contribute to the differing results.  Lastly, we performed but 
did not adjust for multiple tests of SNPs, genetic models, and interactions thus we cannot rule 
out the possibility of false positive findings. We treated each test for association as a separate 
hypothesis and did not subscribe to a global null (Rothman 1990).  
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The present study is the first study that investigated the role of genetic variants in the 
development of hypertension in Filipinos. By exploring potential effect heterogeneity, we 
responded to the call for context-dependent analyses (Franks 2008) and contribute to a 
limited but important body of literature that may help elucidate the complexity of the 
genetics of hypertension. Higher risk genetic environments may be necessary for 
hypertension to develop. The effects of the selected polymorphisms may only be evident 
when other genetic and environmental characteristics are taken into account (Barlassina, 
Schork et al. 2000; Svetkey, Moore et al. 2001; Katsuya, Ishikawa et al. 2003; Tamaki, 
Nakamura et al. 2005; Fava, Montagnana et al. 2007; Franks 2008; Jiang, Sheng et al. 2008). 
We would not have observed the potential role of ACE I/D and ADD1 Gly460Trp 
polymorphisms in hypertension risk if differential effects by age were not explored.  
In summary, the study suggests that AGT Met235Thr polymorphism may play an 
important role in the development of hypertension in adult Filipino women. There is also 
some evidence that ACE I/D and ADD1 Gly460Trp may contribute to hypertension risk in 
older women.  
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Table 4.1. Selected characteristics of CLHNS women in 2005, N=1776 
Characteristic Mean  ± standard deviation or % 
Age, year 48.4 ± 6.02 
Systolic BP, mmHg 119.8 ± 20.0 
Diastolic BP, mmHg 79.8 ± 12.4 
Hypertensive, %  27.9 
Use of anti-hypertensive medications, % 4.0 
BMI, kg/m2 24.3 ± 4.4 
Waist circumference, cm 81.1 ± 10.9 
Overweight (OW) duration, %  
Never OW 47.6 
History of OW 10.2 
OW <3 years 6.2 
OW 3-10 years 11.0 
OW >10 years 25.0 
Education, year 6.8 ± 3.3 
Current smoker, % 14.9 
Alcohol drinker, % 38.1 
Postmenopausal, % 38.4 
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Table 4.2. Effects of AGT, ACE and ADD1 polymorphisms on odds of hypertension, by age 
 N (%)    
 Not 
hypertensive 
 
Hypertensive 
 
Odds Ratio*  
 
95 % CI 
 
p-value 
AGT rs699       
All women      
MetMet 42 (82.4) 9 (17.6) 1.00 (ref)   
MetThr/ThrThr 1222 (71.9) 478 (28.1) 2.57 1.20-5.53 0.016 
ACE rs4331       
<55 years      
DD/DI 646 (73.2) 237 (26.8) 1.00 (ref)   
II 404 (74.3) 140 (25.7) 0.96 0.75-1.25 0.779 
≥55 years      
DD/DI 116 (67.8) 55 (32.2) 1.00 (ref)   
II 44 (49.4) 45 (50.6) 2.53 1.43-4.45 0.001 
All women      
DD/DI 762 (72.3) 292 (27.7) 1.00 (ref)   
II 448 (70.8) 185 (29.2) 1.13 0.90-1.43 0.282 
ADD1 rs4961       
<55 years      
GlyGly 351 (72.7) 132 (27.3) 1.00 (ref)   
GlyTrp/TrpTrp 742 (74.4) 255 (25.6) 0.92 0.71-1.19 0.526 
≥55 years      
GlyGly 59 (71.1) 24 (28.9) 1.00 (ref)   
GlyTrp/TrpTrp 106 (57.6) 78 (42.4) 1.83 1.02-3.27 0.041 
All women      
GlyGly 410 (72.4) 156 (27.6) 1.00 (ref)   
GlyTrp/TrpTrp 848 (71.8) 333 (28.2) 1.02 0.81-1.29 0.846 
*Adjusted for body mass index, waist circumference (high risk or not), overweight duration, cigarette smoking 
(current smoker or not), alcohol consumption (current drinker or not), menopausal status (postmenopausal or 
not), years of education and log of household income. Estimates for all women were additionally adjusted for 
age.  ref = reference group 
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Figure 4.1 (A) 
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Figure 4.1 (B) 
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Figure 4.1. Odds of hypertension comparing genotypes at selected ages. (A) ACE (rs4331) II 
vs DD/DI and (B) ADD1 (rs4961) GlyTrp/TrpTrp vs GlyGly.  Adjusted for age, body mass 
index, waist circumference (high risk or not), overweight duration, cigarette smoking (current 
smoker or not), alcohol consumption (current drinker or not), menopausal status 
(postmenopausal or not), years of education and log of household income.
p = 0.089 p = 0.495 
p = 0.149 
p = 0.007 
p = 0.003 
p = 0.003 
p = 0.161 p = 0.391 
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V. The association between high sodium intake and hypertension in Filipino women 
 is influenced by genetic and environmental factors 
 
A. Abstract 
Background: Studies investigating the effect of dietary sodium on hypertension in 
developing Asian countries are largely lacking. Fewer have investigated heterogeneity of the 
sodium-hypertension association according to different genetic and environmental factors in 
these settings.  Methods and Results: We determined the association between high sodium 
intake (≥4600 mg/day) and hypertension and assessed whether this association was modified 
by gene variants suggested in salt-sensitivity (angiotensinogen (AGT) Met235Thr, 
angiotensin converting enzyme (ACE) insertion/deletion, and alpha adducin, ADD1 
Gly460Trp) and by age, body mass index (BMI), overweight (OW) duration and smoking 
status. We used data from 1776 women participants (age 35-68 years) of the Cebu 
Longitudinal Health and Nutrition Survey collected in 2005. Logistic regression analyses 
showed increased effect of high sodium intake on hypertension in women: (1) with the ADD1 
TrpTrp genotype with adjusted odds ratio (OR, 95% CI: 2.99, 1.44-6.22); (2) who had never 
been OW (2.27, 1.45-3.55); and (3) who were smokers (3.06, 1.51-6.19). Additionally, OR 
increased by 6% for each year increase in age and decreased by 7% for each kg/m2 increase 
in BMI. Effect measure modification by the AGT and ACE variants were not observed. 
Conclusions: With relatively high frequency of the ADD1 460TrpTrp genotype and as the 
population gets older, efforts to reduce sodium intake should be intensified. Women who 
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have lower BMI, those who had never been OW and those who smoke should be especially 
cautioned.   
 
B. Introduction 
Hypertension makes the largest contribution to the worldwide burden of 
cardiovascular diseases (CVD) accounting for almost half of the estimated 16.7 million 
CVD-related deaths per year and a third of CVD-related disability adjusted life years 
(DALYs) (WHO 2002; Mackay and Mensah 2004). Approximately 80% of the burden 
attributed to high blood pressure (BP) is borne by low- and middle-income countries (Lawes, 
Vander Hoorn et al. 2008).  It is a multi-factorial disease that develops from the complex 
interplay of environmental and genetic factors (Pausova, Tremblay et al. 1999).   
The Philippines, a lower middle income country with a population of more than 88 
million, has been undergoing rapid socio-economic changes. The country has not been 
immune to the large shifts in obesity, hypertension and many other non-communicable 
diseases that are occurring across the globe (Kearney, Whelton et al. 2005; Popkin 2008). 
Heart and vascular diseases are ranked as the first and second leading causes of mortality 
accounting for 17% and 13% of deaths, respectively (DOH 2007). Estimated (DALYs) from 
heart disease were estimated to be higher in the Philippines than in the U.S. or China 
(Mackay and Mensah 2004). 
The burden of hypertension among Filipinos may reflect a wide range of factors.  
First, Asians tend to develop hypertension at a lower body mass index (BMI) compared to 
Caucasian populations (Colin Bell, Adair et al. 2002; WHO 2004). Second, many Asians 
 57 
consume high amounts of sodium owing to dietary habits that involve extensive use of added 
salt in the form of high sodium condiments (WHO 2007).    
The role of sodium intake in the development of high BP has not been without 
controversy. Jurgens and Graudal in their systematic review of studies looking at the sodium-
BP relationship concluded that the magnitude of the effect of high sodium intake on BP did 
not warrant a general recommendation to reduce sodium consumption among Caucasians 
(Jurgens and Graudal 2004). Although there was a higher sodium effect on BP in Blacks and 
Asians, the number of studies (8 and 1, respectively) was insufficient to make a different 
recommendation. Nonetheless, the World Health Organization (WHO) declared that the 
evidence supporting the association between high sodium intake and high BP is conclusive 
(WHO 2007). One of the largest and most commonly cited studies that investigated the 
sodium and BP relationship is the INTERSALT. Using data collected from 32 countries, this 
study reported that sodium excretion was significantly related to the slope of BP with age 
(INTERSALT 1988). 
There is less controversy regarding the heterogeneity of BP response to sodium 
intake, raising the notion of salt-sensitivity and salt-resistance (INTERSALT 1988; 
Weinberger 2006). Altered activity of neurohormonal systems and enhanced sodium re-
absorption are among the plausible explanations to the differential response to sodium intake 
(Beeks, Kessels et al. 2004). Thus, genetic factors that affect these processes may play 
important roles and warrant investigation. Studies have suggested the influence of the alpha 
adducin (ADD1) gene variant Gly460Trp which can potentially influence BP by enhancing 
tubular sodium re-absorption (Cusi, Barlassina et al. 1997).  Similarly, the potential effects of 
genes encoding the main components of the renin-angiotensin system (RAS) on the BP 
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response to sodium have been evaluated but results have not been consistent (Beeks, Kessels 
et al. 2004). 
Studies investigating the effects of dietary sodium intake on BP in low and middle 
income countries are largely lacking, especially among Asians from developing countries 
such as the Philippines (WHO 2007). This study determined the association between high 
sodium intake and hypertension in Filipino women and examined whether there is 
heterogeneity in the effect of sodium according to different genetic and lifestyle 
characteristics. For the genetic characteristics, we specifically assessed effect measure 
modification by the following gene variants: angiotensinogen (AGT) Met235Thr, angiotensin 
converting enzyme (ACE) insertion/deletion (I/D) in intron 16, and ADD1 Gly460Trp. These 
variants have been associated with salt-sensitive hypertension and have been shown to 
potentially influence hypertension prevalence in our sample (see Chapter IV).  We also 
examined the roles of age, BMI, overweight duration, and smoking status.  
 
C. Methods 
C.1. Data source and sample  
 The study sample is comprised of participants in the ongoing Cebu Longitudinal 
Health and Nutrition Survey (CLHNS). Details of the CLHNS study design have been 
described previously (Adair and Popkin 2001). Briefly, the CLHNS was conducted in 
Metropolitan Cebu, one of the main metropolitan areas in the Philippines. In 1983, a 
stratified, single stage sampling design was used to randomly select 33 barangays (villages in 
rural areas, neighborhoods in urban areas) and all pregnant women in the selected barangays 
were initially invited to participate.  Women   were included in the survey if they gave birth 
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between May 1, 1983 and April 30, 1984 (n=3327). Follow-up surveys were conducted in 
1991, 1994, 1998, 2002, 2005 and 2007. 
For this study, the sample is limited to 1789 women who provided a blood sample in 
the 2005 survey, who had information on at least one of the polymorphisms, and who did not 
have an apparent first degree relative in the study based on predicted identity by descent 
estimates from 95,000 SNPs using PLINK (http://pngu.mgh.harvard.edu/purcell/plink/) (data 
not shown) (Purcell, Neale et al. 2007) . We excluded women who were pregnant (n=8) and 
those missing BP measurements (n=5) for an analysis sample size of 1776.   
 
C.2. Analysis variables 
 BP. We used data taken during the 2005 survey. BP was measured using a mercury 
column sphygmomanometer after a 10 minute rest when the woman was seated. The mean of 
three measurements was used to represent systolic BP and diastolic BP. Women reported all 
medications they were taking which were then classified according to their uses by a 
registered nurse. Hypertension was defined as systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 
mmHg or taking anti-hypertensive medications (Chobanian, Bakris et al. 2003).  
 Sodium Intake. The CLHNS collected two 24-hour dietary recalls that were 
supplemented by semi-structured questions on the usual intake of salty condiments added 
during cooking or at the table. Women were asked the frequency, amount and method of use 
of added salty condiments that included table salt, soy sauce, fish sauce, monosodium 
glutamate (MSG) and other high sodium flavorings. Dietary data were reviewed by licensed 
and trained nutritionists and implausible values were immediately identified and verified by 
revisits. Philippine Food Composition Tables (FCT) produced by the Food and Nutrition 
 60 
Research Institute (FNRI) of the Philippines and regularly updated by an Office of 
Population Studies Foundation resident nutritionist were used to calculate energy and 
nutrient intakes. For foods missing sodium content information in the Philippine FCT, we 
used values from the China FCT. 
Total sodium intake was estimated as the sum from foods and from added 
condiments. Women who consumed at least 4600 mg of sodium per day were classified as 
having high sodium intake. This cutpoint is equivalent to 200% of the recommended upper 
limit for adults (IOM 2004) and has been used in sodium-BP clinical trials to represent high 
sodium intake (MacGregor, Markandu et al. 1989; van der Kleij, de Jong et al. 2002). This 
corresponds to the 85th percentile of total sodium intake of our study sample.    
Genotyping. We selected three genetic polymorphisms suggested to be implicated in 
the development of high BP or essential hypertension (Jeunemaitre, Soubrier et al. 1992; Niu, 
Chen et al. 2002; Bianchi, Ferrari et al. 2005; Arnett, Baird et al. 2007) and shown to have 
minor allele frequency of >0.01 in Asian populations (Higaki, Baba et al. 2000; Ju, Zhang et 
al. 2003; Tamaki, Nakamura et al. 2005; Cha, Kim et al. 2007).  These included the 
Met235Thr polymorphism of AGT (rs699, Met=T, Thr=C), Gly460Trp polymorphism of 
ADD1 (rs4961, Gly=G, Trp=T), and I/D polymorphism of ACE represented by rs4331 (G/A 
alleles). Variant rs4331 was reported to be in linkage disequilibrium (D’=1.000, r2 =0.967) 
with ACE I/D among 511 Japanese and can be more conveniently genotyped than the latter 
(Rieder, Taylor et al. 1999; Tanaka, Kamide et al. 2003). DNA was isolated from blood using 
the Gentra Puregene protocol and genotyping was performed using TaqMan allelic 
discrimination assays (Applied Biosystems, Foster City, CA). Genotype distributions of the 
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three polymorphisms were consistent with Hardy-Weinberg equilibrium, with Pearson chi-
square test p-values >0.05.  
Covariates. Anthropometric measurements were taken by trained personnel at home 
while participants were wearing light clothing. Weight was measured using portable scales 
while height was measured using portable stadiometers. BMI was calculated as weight in kg 
divided by squared height in meters. To determine overweight duration, we created a binary 
variable indicating whether the non-pregnant woman was overweight (OW = BMI ≥  25 
kg/m2) (WHO 2000) for each survey round from baseline to 2005. These binary OW 
variables were examined for patterns over time and were used to group women into five OW 
duration categories – never OW, with OW history (not OW in 2005 but have been OW in at 
least 1 survey), OW < 3 yrs, OW 3-10 yrs, and OW > 10 yrs.  Indicator variables were used 
to represent each OW duration category. Waist circumference was measured using standard 
measuring tapes and was deemed high risk if ≥ 88 cm (WHO 2000). 
Other variables of interest were collected through in-home face-to-face interviews 
using structured questionnaires. Age (years), log of household income, education (number of 
years of formal schooling), and number of pregnancies were used as continuous variables. 
Indicator variables were created to represent levels of occupational physical activity (not 
working, sedentary, light, moderate, or heavy) based on detailed occupation codes, posture at 
work and physical demands of jobs. Binary indicator variables were created for smoking 
status (current smoker or not), alcohol consumption (current drinker or not) and menopausal 
status (postmenopausal or not).  We used a community level continuous urbanicity index 
variable (0-70 scale) based on population size and density, community infrastructure, 
economic and environment characteristics of the woman’s barangay of residence in 2005. 
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This index has been validated and found to be a better measure of urbanicity than the urban-
rural dichotomy (Dahly and Adair 2007). Mean total energy intake (kcal) and calcium intake 
(mg/day) were estimated from two 24-hour recalls.   
We obtained informed consent from all participants. The study protocol was approved 
by the University of North Carolina Institutional Review Board for the Protection of Human 
Subjects.  
 
C.3. Statistical analysis  
Differences in proportions and means of selected characteristics of women in 2005 
according to sodium intake (lower versus high) were compared using chi-square test and t-
test, respectively. We used logistic regression to estimate the effect of sodium intake on 
hypertension. To determine whether the association between sodium intake and hypertension 
was modified by the selected genetic polymorphisms and other covariates, we employed the 
likelihood ratio (LR) test where models with and without interaction terms (i.e. sodium 
intake X gene, sodium intake X covariates) were compared. Significant effect measure 
modification was set at LR test chi-square p-value <0.10.  Higher alpha was specified since 
homogeneity tests have lower power to detect differences (Rothman and Greenland 1998). 
Among the lifestyle factors, we found age, BMI, OW duration, and smoking status to be 
significant effect measure modifiers, thus these variables were retained in the model. We also 
adjusted for total daily energy intake. To estimate the effect of sodium intake on 
hypertension according to levels or categories of the effect measure modifiers, separate 
analyses were conducted for each modifier. For example, to estimate the effect of high 
sodium intake for women at different ages, we used a model with sodium, age and sodium-
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age product term and controlled for BMI, OW duration, smoking status and total energy 
intake. Models examining effect measure modification for each of the genetic variants 
controlled for age, BMI, OW duration, smoking status and total energy intake. Additionally 
controlling for other covariates did not substantially (at least 10%) change the exposure-
outcome effect estimates. We evaluated attrition bias by weighting the observations by the 
reciprocal of the probability of being in the study sample (Fitzgerald, Gottschalk et al. 1998).  
Since the weighted analyses were not substantially different from the un-weighted analyses, 
we present un-weighted results. STATA/SE version 10.1 (StataCorp, College Station, TX) 
was used in all analyses.  
 
D. Results 
Mean sodium consumption in 2005 was about 2900 mg of sodium per day, with 
49.9% of women consuming more than the recommended upper limit (2300 mg/day) and 
14.9% consuming at least 4600 mg/day. Salty condiments added during cooking or at the 
table accounted for 76.3% of sodium intake (Table 5.1). The most significant source of 
sodium was table salt, contributing 53.3% for women who consumed <4600 mg/day of 
sodium and 66.5% for women who consumed higher amounts of sodium.  
We found no significant differences in women’s age, diastolic BP, BMI, waist 
circumference, occupational physical activity, education, smoking habits, alcohol 
consumption and genotype distributions between groups defined by sodium intake. Women 
with higher sodium intake (≥4600 mg) were more likely to be hypertensive and less likely to 
had never been OW (Table 5.2). Almost 28% of the sample women were hypertensive.  
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 Logistic regression analyses controlling for age, BMI, OW duration, smoking status 
and energy intake, showed that high sodium intake increased hypertension odds (odds ratio 
(OR) (95% CI): 1.39 (1.03-1.87). The association between sodium intake and hypertension 
did not differ by ACE I/D and AGT Met235Thr polymorphisms but significantly differed by 
ADD1 Gly460Trp polymorphism. For women with the ADD1 GlyGly and GlyTrp genotypes, 
the OR for hypertension comparing women with high sodium intake to those with lower 
sodium intake were 1.03 (0.62-1.72) and 1.32 (0.87-2.01), respectively (Table 5.3). However, 
for women with TrpTrp genotype, high sodium intake was associated with a nearly 3 fold 
(2.99 (1.44-6.22)) increase in the odds of hypertension compared to the odds for women with 
lower sodium intake (Table 5.3). The effect estimates for ADD1 GlyGly and GlyTrp 
genotypes were not significantly different from each other but were different from the effect 
estimate for TrpTrp genotype.  
Additionally, we found effect measure modification by age, BMI, OW duration and 
smoking status. The effect of high sodium intake on hypertension increased with age (Figure 
5.1). For each year increase in age, the OR increased by 6%. For example, using coefficients 
from the logistic regression model, the estimated OR for hypertension comparing women 
with high sodium intake to women with lower sodium intake was 0.81 (0.47-1.39) for 40 
year old women but was 2.62 (1.44-4.75) for 60 year old women. The reverse was true for 
BMI. The association between high sodium intake and hypertension decreased with 
increasing BMI (7% decrease for each unit increase in BMI); high sodium intake was not 
associated with hypertension in women with BMI >25 kg/m2 (Figure 5.2). Similarly, we 
found that increased odds of hypertension was associated with high sodium intake only for 
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never OW women (Table 5.3). Smoking magnified the effect of sodium on hypertension 
from 1.18 (0.85-1.64) for non-smokers to 3.06 (1.51-6.19) for smokers.  
We further explored whether the association between high sodium intake and 
hypertension significantly differed by age, BMI (OW or not), and OW duration categories if 
we stratify women according ADD1 Gly460Trp genotype (ADD1 GlyGly/GlyTrp versus 
TrpTrp). Women with ADD1 GlyGly and GlyTrp were combined since the effect of high 
sodium intake on hypertension in these groups did not significantly differ. We found that the 
effects of age on the association between high sodium intake and hypertension were similar 
regardless of ADD1 genotype – for each year increase in age, the effect of high sodium 
intake on hypertension prevalence increased by 6%. For BMI, we observed that the weaker 
effect of sodium on hypertension for OW women was true primarily for women carrying one 
or more Gly alleles (Table 5.4). The same pattern is seen for OW duration. We did not find 
significant effect measure modification by OW status or duration among women 
homozygous for the Trp allele.  
 
E. Discussion 
To the best of our knowledge, this population-based study is the first to examine the 
effect of consuming high amounts of sodium on hypertension in Filipinos. We found that 
high sodium intake (≥ 4600 mg/day) increased the risk of hypertension among adult women 
in this population and that the degree of the adverse effect varied according to certain genetic 
and lifestyle factors. The effect of high sodium intake on hypertension prevalence was 
greater in women with the ADD1 TrpTrp genotype (versus GlyGly or GlyTrp), women who 
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were older, had lower BMI especially those who had never been overweight, and among 
smokers.  
The effect of dietary sodium on hypertension risk may be influenced by the ADD1 
Gly460Trp polymorphism by enhancing renal tubular sodium re-absorption (Bianchi 2005). 
This mechanism may be driven by an increase in Na-K pump activity and a deficiency of Na-
K pump endocytosis that were observed in cells transfected with the ADD1 Trp allele 
compared to cells with the Gly allele (Efendiev, Krmar et al. 2004; Bianchi 2005). The 
TrpTrp genotype was also shown to be associated with reduced renal plasma flow and 
glomerular filtration rate as compared to the GlyGly genotype (Beeks, van der Klauw et al. 
2004). In fact, the different BP response to sodium according to ADD1 Gly460Trp variant 
had been previously reported (Cusi, Barlassina et al. 1997; Grant, Romero et al. 2002). In a 
salt-sensitivity test designed to assess acute BP response to changes in body sodium in 86 
hypertensive patients, Cusi et al found that the decrease in mean arterial pressure (MAP) was 
greater in patients who were heterozygous for the mutant allele (Gly/Trp) than in Gly/Gly  
homozygotes (mean decrease 15.9 versus 7.4 mmHg; p = 0.001). With only 2 subjects 
having the TrpTrp genotype, this group was not included in the analysis (Cusi, Barlassina et 
al. 1997). Similarly, Grant et al examined 279 subjects and found greater systolic BP 
increment in response to the change from low (~230 mg/day) to high sodium diet (~4600 
mg/day) in subjects homozygous for the TrpTrp allele (25+/-4 mmHg) compared to 
heterozygous (12+/-2 mmHg) or homozygous for the Gly allele (14+/-1 mmHg) (Grant, 
Romero et al. 2002). In line with our results, there was no significant difference in the BP 
response to sodium intake between the GlyGly and GlyTrp subjects. However, a population-
based cross-sectional study of 2823 Japanese men and women found a significant interaction 
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between sodium excretion and the Gly460Trp polymorphism on systolic BP in men but not 
in women (Yamagishi, Iso et al. 2004). Mean systolic BP was 5.2 mmHg higher in the 
TrpTrp group compared to the GlyGly group in men with higher sodium excretion (≥4350 
mg/day) but not in men with lower sodium excretion. For men with higher sodium excretion, 
mean systolic BP of the GlyGly group was similar to the GlyTrp group (133.6 versus 134.6 
mmHg).  
Older age is associated with increased sodium sensitivity, a steeper BP and 
exchangeable body sodium relationship, decreased gain of the baroreceptor reflex, reduced 
renal perfusion, and a compromised  buffering effect of large arteries on systolic and 
diastolic pressure (Staessen, Wang et al. 2003). These mechanisms may explain the 
increasing hypertensive effect of high sodium intake with increasing age observed in our 
sample. This finding supports most of the studies that examined potential age-dependent 
sodium and BP association. The INTERSALT study, one of the largest population based 
studies that examined the association between sodium excretion and BP with 10079 
participants (age 20-59) recruited from 32 countries, showed that in populations with high 
salt intake, the association between age and BP was steeper than in those with low salt intake 
suggesting a positive age and salt intake interaction (INTERSALT 1988). Law et al analyzed 
published reports of BP and sodium intake (47000 people from 24 communities around the 
world) and found that a difference of 2300 mg/day was associated with an average difference 
in systolic BP that ranged from 5mmHg at age 15-19 to 10mmHg at age 60-69 years (Law, 
Frost et al. 1991). The well-known Dietary Approaches to Stop Hypertension (DASH)-
sodium trial where participants were given 3 levels of sodium (1150, 2300, 3450 mg/2100 
kcal) for 30 days while consuming the DASH diet or a more typical American diet showed 
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that age had a strong and graded influence on the effect of sodium on BP: sodium intake 
reduction from 3450 to 2300mg/2100 kcal and reduction from 2300 to 1150 mg/2100 kcal 
resulted in reduction of systolic BP by 4.8 and 1.0 mmHg for 23 to 41 years, 5.9 and 1.8 mm 
Hg for 42 to 47 years, 7.5 and 4.3 mm Hg for 48 to 54 years, and 8.1 and 6.0 mm Hg for 55 
to 76 years (Bray, Vollmer et al. 2004).  Results of a recent dietary feeding (GenSalt) study 
in China with 1906 participants corroborated these findings (He, Gu et al. 2009).  
It has been suggested that excess weight or obesity may enhance the hypertensive 
effect of sodium (Weinberger 2006). Hyperinsulenemia (Rocchini, Key et al. 1989; Reaven, 
Lithell et al. 1996; Muscelli, Camastra et al. 1998), increased renal sodium re-absorption and 
a blunted response to natriutic hormones (Hall, Jones et al. 2003; Chalmers, Kaskel et al. 
2006; Mathew, Patel et al. 2007) that can accompany excess weight are possible mechanisms 
that may lead to different BP responses to sodium intake. However, a positive interaction of 
the effects of BMI and sodium intake on hypertension has not been consistently shown. In a 
study involving 60 obese and 18 non-obese adolescents, a change from a high salt to a low 
salt diet resulted to a larger mean change in mean arterial pressure (MAP) in the obese group 
suggesting salt sensitivity (Rocchini, Key et al. 1989). A 24-week, placebo-controlled, two-
period, crossover trial of sodium supplementation in 112 African Americans, aged 25 to 64 
years, showed that variability-adjusted BP change correlated with BMI (Flack, Grimm et al. 
2002). However, a double-blind randomized study of 46 white non-obese subjects aged 25 to 
80 years showed that salt-sensitive subjects had lower body weight than salt-resistant 
individuals and that subjects with a BMI <26 kg/m2 showed a rise in MAP when moving 
from a low sodium to a high sodium diet, whereas subjects with BMI >26 kg/m2 did not 
(Overlack, Ruppert et al. 1995). Prolonged OW or obesity has also been associated with 
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insulin resistance and hyperinsulinemia (Muscelli, Camastra et al. 1998; Janssen, 
Katzmarzyk et al. 2004), and gradual loss of kidney function that worsens with time 
(Wofford and Hall 2004) but no other study has examined the modifying effect of OW 
duration on the sodium-BP relationship. Our results showed that the effect of higher sodium 
intake on hypertension risk was decreased as BMI and OW duration increased. It may be 
because excess weight (Garrison, Kannel et al. 1987; Must, Spadano et al. 1999; Davy and 
Hall 2004) and being OW for a longer duration (Janssen, Katzmarzyk et al. 2004) are very 
strong predictors of hypertension risk such that the effects of other factors including high 
sodium intake will not add considerable observable risk. Although the increased risk of 
hypertension in non-OW or never OW women attributed to high sodium consumption has not 
been shown or investigated in other Asian populations, this may partly explain why Asians 
tend to develop hypertension at lower BMI.  
 We showed that the effect of high sodium intake was heightened in smokers 
compared to non-smokers. We have not found previous studies that investigated whether the 
effect of high sodium intake on hypertension differ by smoking habits. Nonetheless, smoking 
has been shown to affect systemic and intrarenal hemodynamics that may lead to renal 
functional impairment (Orth 2004). It may be possible that these processes may affect 
sodium re-absorption.  
 This study has certain limitations. First, sodium intake was estimated using dietary 
recalls and a food frequency questionnaire which are more prone to measurement errors 
compared to 24-hour urine collections (WHO 2007).  Sodium intake was likely 
underestimated but we do not believe that the degree of underestimation or error was 
differential. Also, setting a relatively high cut-point may reduce the probability of 
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misclassifying women with high sodium intake. Second, the reduction in sample size from 
baseline (1983/84) to 2005 may introduce selection bias and limit the generalizability of 
results. Compared to women who were not in the 2005 sample, the women included in this 
study had lower baseline BMI (20.8 versus 20.6 kg/m2), were older (age at baseline: 26.3 
versus 26.8 years) and had less years of education (8.0 versus 7.2 years). However, the main 
reason for attrition was migration to areas outside of Metropolitan Cebu and it is unlikely that 
this was associated with sodium intake and having hypertension. Results of analyses 
weighted by the reciprocal of the probability of being in the study sample were not different 
from those of un-weighted analyses indicating no significant attrition bias. Third, we used 
cross-sectional data and cannot establish that high sodium intake preceded the development 
of hypertension. But, it is more likely that having hypertension will result in reduced rather 
than increased sodium intake; therefore reverse causation will more likely bias the estimates 
to the null. Lastly, the 3 BP measurements that were averaged to represent BP were taken on 
the same day and cannot account for day-to-day variations. This may cause regression 
dilution and result in attenuated results (Rothman and Greenland 1998).  
This study is the first to determine the effect of high sodium diet on hypertension in 
Filipinos, a population inflicted with high rates of hypertension and other CVD and who 
consume relatively high amounts of sodium. We add to the scant literature exploring 
heterogeneity of the effect of sodium consumption on hypertension according to genetic 
variants and known environmental hypertension risk factors. With rich dietary, 
anthropometric, demographic and lifestyle data we were able to assess confounding of other 
variables.  Additionally, we explored and showed potential 3-way interactions of sodium 
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intake, ADD1 Gly460Trp and BMI or OW duration. This can guide future studies with larger 
sample sizes to assess these interactions.  
Examining 23 countries that account for 80% of the burden of chronic disease in low- 
and middle-income regions of the world, Asaria et al estimated that the Philippines, along 
with China and Egypt, would have the most to gain by salt reduction interventions (in terms 
of deaths averted by interventions as a proportion of total possible deaths from chronic 
disease) (Asaria, Chisholm et al. 2007). The findings of this study support the intensification 
of programs designed to reduce salt intake in the country. First, we found that the frequency 
of the higher risk ADD1 Trp allele (43%) or the TrpTrp genotype (19%) in our sample is 
higher compared to Caucasians (~18-27% and ~2-4%, respectively) (Cusi, Barlassina et al. 
1997; Staessen, Wang et al. 2001; Grant, Romero et al. 2002; Fava, Montagnana et al. 2007). 
Second, our results indicate that greater benefits may be observed in older individuals of 
whom the rate of CVD can potentially increase at a faster rate (Bray, Vollmer et al. 2004; 
Mackay and Mensah 2004). Third, in our sample, about 21% of non-OW and 19% of never 
OW women were hypertensive and our findings suggest that this may be driven by high 
sodium consumption. Thus, to reduce hypertension in the population, it is imperative that 
these groups of women, who are most likely presumed to be at low risk for hypertension, 
should be especially cautioned against high sodium intake.  
To effectively design policies for sodium reduction, it is useful to determine the major 
sources of dietary sodium in the population. In Western industrialized countries such as the 
UK and US about 75-77% of the sodium intake were estimated to come from restaurant 
foods or processed foods (James, Ralph et al. 1987; Mattes and Donnelly 1991; WHO 2007). 
In contrast, the dietary sodium source in our sample was similar to those observed in other 
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East Asian populations where added salty condiments, especially salt added during cooking 
or at the table constituted majority of the sodium intake. For example, in China, added salt 
during cooking contributed 75-78% of dietary sodium; an additional 8% was from soy sauce 
(WHO 2007). Moreover, the use of added salt appeared to drive the higher sodium 
consumption in our sample. It should be noted that the use of these sources are well within 
the control of individuals, thus, programs for reducing salt consumption in the Philippines 
and other East Asian countries could concentrate on encouraging the public to reduce the use 
of added salt and other salty condiments in the household more than or in addition to 
reducing sodium used during food processing (such as advocated in the US). Iodine 
deficiency remains a public health concern in the country and salt iodization has been used as 
a primary strategy to eliminate this disorder. However, with the adverse effects of high salt 
consumption on BP and consequently on CVD, alternate strategies or iodization of other 
commonly consumed foods should be promoted to avoid potentially conflicting public health 
messages. As the WHO stated “the promotion of salt consumption overall to prevent iodine 
deficiencies is unnecessary. Therefore the implementation of a universal salt iodization 
program should not induce individuals to perceive that increased salt consumption is needed 
to prevent iodine deficiencies” (WHO 2007).  
In summary, the results of this study underscore the importance of heeding the WHO 
recommendation for population-wide reduction in salt intake to decrease CVD burden 
attributable to high BP, especially with a relatively high frequency of the ADD1 Trp460Trp 
genotype and as the Philippine population gets older. Maximum benefits may be achieved if 
these programs are accompanied by continued efforts to discourage smoking. For OW 
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women, it might be more sensible to focus on other hypertension prevention strategies (i.e. 
for reducing weight) first.  
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Table 5.1. Percent distribution of sodium sources among women in 2005 
 
Source 
All women 
n = 1776 
Lower sodium*  
n = 1512 
High sodium*   
n = 264 
Chi-square 
p-value 
Foods/Diet 23.7 27.6 16.7 <0.01 
Salt 58.1 53.3 66.5  
Soy sauce 13.9 14.7 12.4  
Fish sauce 1.4 1.4 1.4  
MSG 2.4 2.5 2.1  
Other flavorings 0.6 0.4 0.8  
*
 Lower sodium: intake < 4600 mg/day; higher sodium: intake ≥ 4600 mg/day. 
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Table 5.2. Selected characteristics of women in 2005, by sodium intake*  
 
Characteristic 
Lower sodium* 
n = 1512 
High sodium* 
n = 264 
 
p-value 
Sodium intake, mg/day 2173.8 ± 1029.9 7064.2 ± 3805.4 <0.01 
Age, years 48.5 ± 5.9 48.4 ± 6.5 0.97 
Systolic BP, mmHg 119.4 ± 20.1 121.9 ± 19.3 0.06 
Diastolic BP, mmHg 79.8 ± 12.5 79.8 ± 12.0 0.93 
Hypertensive, % 26.8 33.7 0.02 
BMI, kg/m2 24.3 ± 4.4 24.7 ± 4.4 0.16 
Waist circumference, cm 81.1 ± 11.0 81.3 ± 11.0 0.80 
OW duration, %   0.04 
Never OW 48.4 43.2  
History of OW† 10.7 7.2  
OW <3 years 5.7 9.1  
OW 3-10 years 10.7 12.9  
OW >10 years 24.5 27.6  
Occupational PA, %   0.36 
Not working 21.1 18.2  
Sedentary 6.4 4.5  
Light 47.9 52.3  
Moderate 16.9 18.9  
Heavy 7.7 6.1  
Education, y 6.8 ± 3.3 6.7 ± 3.3 0.55 
Current smoker, % 14.5 17.0 0.28 
Alcohol drinker, % 38.0 38.6 0.85 
ACE (rs4331), N (%)   0.33 
DD 215 (14.9) 31 (12.4)  
DI 693 (48.2) 115 (46.2)  
II 530 (36.9) 103 (41.4)  
ADD1 (rs4961), N (%)   0.11 
GlyGly 472 (31.8) 94 (35.9)  
GlyTrp 721 (48.5) 130 (49.6)  
TrpTrp 292 (19.7) 38 (14.5)  
AGT (rs699), N (%)   0.32 
MetMet 45 (3.0) 6 (2.3)  
MetThr 379 (25.4) 77 (29.6)  
ThrThr 1067 (71.6) 177 (68.1)  
*
 Values are means ± standard deviation, unless otherwise indicated. Lower sodium: intake < 4600 mg/day; 
higher sodium: intake ≥ 4600 mg/day. † Women were not OW in 2002 survey but have been OW for at least 1 
survey.  
BP = blood pressure; BMI = body mass index; OW= overweight; PA = physical activity.  
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Table 5.3. Odds ratios (95% CI) for hypertension comparing high to low sodium intake 
(reference) among women, by ADD1 genotype, OW duration, and smoking status 
 n Odds Ratio* 95% CI 
ADD1 (rs4961) †     
GlyGly 566 1.03 0.62-1.72 
GlyTrp 851 1.32 0.87-2.01 
TrpTrp 330 2.99 1.44-6.22 
OW duration‡     
Never OW 845 2.27  1.45-3.55 
History of OW 181 0.99  0.34-2.89 
OW <3 years 110 2.22 0.79-6.26 
OW 3-10 years 196 0.84 0.38-1.88 
OW >10 years 444 0.89 0.53-1.52 
Current smoking status§     
Non-smoker 1512 1.18 0.85-1.64 
Smoker 264 3.06 1.51-6.19 
*
 Low sodium intake: < 4600 mg/day; high sodium intake: ≥ 4600 mg/day. †Adjusted for age, BMI, OW 
duration, current smoking status and energy intake. Likelihood Ratio (LR) test chi-square p-value = 0.06. 
‡Adjusted for age, BMI, current smoking status and energy intake. LR test chi-square p-value = 0.04. §Adjusted 
for age, BMI, OW duration, and energy intake. LR test chi-square p-value = 0.02.  
ADD1 = alpha adducin; BMI= body mass index; OW = overweight.  
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Table 5.4. Odds ratios (95% CI) for hypertension comparing high to low sodium intake 
(reference) among women* stratified by BMI and OW duration categories, by ADD1 
genotype 
 ADD1 
GlyGly/GlyTrp 
n ADD1 
TrpTrp  
n 
BMI†, kg/m2     
< 25 1.83 (1.16-2.88) 815 2.65 (0.94-7.45) 198 
≥ 25  0.79 (0.50-1.23) 602 3.13 (1.07-9.16) 132 
LR test chi-square p-value <0.01  0.82  
OW duration‡     
Never OW 2.07 (1.26-3.40) 673 3.53 (1.17-10.64) 163 
OW < 3 years 2.48 (0.77-8.00) 86 1.20 (0.11-12.92) 20 
OW 3-10 years 0.76 (0.32-1.77) 161 1.91 (0.13-26.48) 33 
OW ≥ 10 years 0.64 (0.35-1.16) 355 5.10 (1.13-23.10) 79 
LR test chi-square p-value 0.02  0.88  
*
 Low sodium intake: < 4600 mg/day; high sodium intake: ≥ 4600 mg/day. † Adjusted for age, OW duration, 
current smoking status, and energy intake. ‡ Adjusted for age, BMI, current smoking status and energy intake. 
BMI= body mass index; OW = overweight; LR = Likelihood Ratio. 
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Figure 5.1. Estimated odds ratios with 95% confidence intervals (CI) for hypertension 
comparing women with high sodium intake to women with low sodium intake (reference) at 
selected ages. Adjusted for body mass index, overweight duration, current smoking status, 
and total energy intake. LR test chi-square p-value comparing models with and without the 
sodium intake (0,1) and age (continuous) interaction term = 0.01.     
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Figure 5.2. Estimated odds ratios with 95% confidence intervals (CI) for hypertension 
comparing women with high sodium intake to women with low sodium intake (reference) at 
selected body mass indices (BMI). Adjusted for age, overweight duration, current smoking 
status, and energy intake. LR test chi-square p-value comparing models with and without the 
sodium intake (0,1) and BMI (continuous) interaction term = 0.01. 
  
 
 
 
VI. Synthesis 
 
A. Overview of findings 
 This research examines the roles of overweight duration, genetic variants and sodium 
consumption on hypertension risk among adult Filipino women in Cebu, Philippines. In 
addition, this research explored potential heterogeneity of the effects of each of these factors 
according to different genetic and environmental characteristics. We used data gathered by 
the Cebu Longitudinal Health and Nutrition Survey (CLHNS). Aside from detailed 
individual, household and community level socio-demographic characteristics, this survey 
provided genetic information, repeated anthropometric measures that span more than two 
decades, dietary measures including sodium intake, and repeated blood pressure (BP) 
measurements. This offered a unique opportunity to address information gaps by improving 
our understanding of the effects of key exposures on hypertension risk and looking at gene-
gene and gene-environment interactions.  First, we examined whether the five-year 
cumulative incidence of hypertension is influenced by the duration of being overweight 
(OW) independent of current weight status. Second, we examined the effects of selected 
genetic variants on the prevalence of hypertension and explored potential gene-gene, gene-
age, and gene-BMI interactions. Lastly, we estimated the effect of sodium intake on the 
prevalence of hypertension and determined whether its effect differed according to important 
hypertension risk factors including the significant exposures we identified in the first two 
phases. This section provides a summary and synthesis of our key findings. 
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A.1. Overweight duration increased the five-year cumulative incidence of hypertension 
regardless of current weight status in Filipino women 
We aimed to examine the relationship between OW duration and five-year 
cumulative incidence of hypertension by using anthropometric data repeatedly measured 
before the onset of hypertension (in 1983/84, 1991, 1994, 1998, and 2002) and by using BP 
measured in 2002 and 2007 to identify incident hypertension. We hypothesized a positive 
relationship between OW history and incident hypertension, independent of 2002 BMI.  We 
used poisson regression with the robust error variance to estimate the effect of OW history 
and duration on hypertension risk in 1607 women. 
We found that OW prevalence in our sample increased 9-fold from 1983/84 to 2002. 
Interestingly, for most women, once they became OW, they remained OW. These present an 
alarming scenario since our analyses confirmed our hypothesis. We observed that the average 
5-year risk for hypertension increased with increasing duration of being OW, independent of 
current BMI. Increased risk became more evident for women who had been OW for more 
than 10 years. Additionally, we illustrated that a longer OW duration increased the risk of 
developing hypertension to a greater extent even at a lower initial BMI. Thus, in addition to 
pathologic processes associated with having excess weight, there may be compounding 
factors associated with constant, long-term elevation of body weight. These findings 
underscore the importance of preventing weight gain and accumulation of excess weight 
earlier in life. We contribute to the elucidation of the pathogenesis of a complex disease such 
as hypertension. However, it is also worth pointing out that a substantial proportion of 
hypertensive women are not OW, leading us to explore other key factors suggested to 
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influence hypertension risk, particularly the influence of genetic variants and sodium 
consumption.  
 
A.2. Genetic variants influence hypertension risk in Filipino women 
 Variants of the angiotensinogen (AGT, Met235Thr), angiotensin converting enzyme 
(ACE, intron 16 insertion/deletion (I/D)) and alpha adducin (ADD1 Gly460Trp) genes have 
been suggested to be associated with the development of hypertension in Caucasians and 
other East Asians. Mainly using data from the 2005 survey of the CLHNS, we aimed to 
examine the association between these genetic variants and hypertension risk in a sample of 
1776 Filipino women. Acknowledging that the effect of each genetic variant may be 
dependent on other genes and individual characteristics, we explored potential gene-gene, 
gene-BMI and gene-age interactions. We hypothesized that these variants influence 
hypertension risk and that their effects vary according to age, BMI and the presence of the 
other variants. To achieve our aims we used logistic regression analysis and tested 
heterogeneity of effects through likelihood ratio tests.  
 In 2005, more than a quarter of the sample women were hypertensive. Of the three 
gene variants, it appeared that the AGT Met235Thr has the strongest influence on 
hypertension risk as judged by the magnitude of odds ratios. The odds of having 
hypertension among women with the 235Thr allele was more than double compared to 
women with the MetMet genotype. This magnitude of effect was observed regardless of age, 
BMI, and ACE I/D and ADD1 Gly460Trp genotypes. For the ACE and ADD1 variants, we 
found age-dependent effects. Specifically, we observed that the effects of the ACE II 
genotype (compared to DD/DI) and the ADD1 GlyTrp/TrpTrp genotypes (compared to 
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GlyGly) increased with age and may only be significant for women aged at least 55 years.  
This study suggests that these genetic variants may contribute to the development of 
hypertension in adult Filipino women, especially the AGT Met235Thr variant. There is also 
some evidence that ACE I/D and ADD1 Gly460Trp may contribute to hypertension risk in 
older women.  These findings become more important as the population gets older. Adding to 
the significance of these observations is that the higher risk genotypes are relatively more 
common in our sample (and other East Asians) than in Caucasians.  
Possible increased sodium re-absorption in the kidney appears to be a common 
mechanism proposed to explain how these variants may influence BP. Thus, dietary sodium 
intake may be particularly important in the development of hypertension in our sample as 
well as other East Asians who tend to consume high amounts of sodium. We investigated this 
proposition in the last section of this research. 
 
A.3. The association between high sodium intake and hypertension in Filipino women is 
influenced by genetic and environmental factors 
 Primarily using data from the 2005 survey of the CLHNS, we determined the 
association between high sodium intake (≥4600 mg/day) and hypertension in Filipino women 
and examined whether there is heterogeneity in the effect of sodium according to different 
genetic and environmental characteristics. For the genetic characteristics, we specifically 
assessed effect measure modification by the genetic variants that we have previously 
investigated and observed to possibly influence hypertension risk in our sample: AGT 
Met235Thr, ACE I/D, and ADD1 Gly460Trp. For the environmental characteristics, we 
examined the potential modifying role of age, BMI, OW duration, and smoking status. We 
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hypothesized that high sodium intake is positively associated with hypertension risk in 
Filipino women and further, that its effect is not homogenous across women with different 
characteristics. To answer our research questions, we used logistic regression analysis and 
tested heterogeneity of effects through likelihood ratio tests.  
 We observed that the main source of dietary sodium in our sample was salt and salty 
condiments added during cooking or at the table, and this may drive the high sodium 
consumption.  
Results of the multivariate analyses suggest that the effect of high sodium intake on 
hypertension is heightened in women with the ADD1 TrpTrp genotype and is not evident in 
women with the GlyGly or GlyTrp genotypes. For women with the ADD1 TrpTrp genotype, 
the odds of having hypertension in women consuming high amounts of sodium was 3 times 
higher than women consuming lower amounts of sodium. The AGT and ACE variants did not 
seem to modify the effect of high sodium intake on hypertension risk. We also found that the 
effect of high sodium intake on hypertension is increased with increasing age, in women who 
had never been OW and those who were smokers. In contrast, the effect of high sodium 
intake decreased with increasing BMI. Further exploration suggests a potential 3-way 
interaction between sodium intake, ADD1 Gly460Trp polymorphism, and BMI and OW 
duration. It may be possible that the weaker effect of high sodium intake associated with 
increased BMI is only true for women carrying the Gly allele. We propose that future studies 
with larger sample sizes explore these 3-way interactions. Based on our findings, we suggest 
that programs designed to reduce sodium consumption should be intensified and focus on 
decreasing the use of salty condiments added during cooking or at the table. Women who are 
older, who are not OW and those who had never been OW, and women who smoke should 
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be specially cautioned against the adverse effect of high sodium consumption. In addition, 
these results may partly explain why Asians tend to develop hypertension at lower BMI.  
Overall, this research found that duration of being OW, selected genetic variants and 
sodium intake influenced hypertension risk in Filipino women. Our findings can guide 
hypertension prevention efforts in the Philippines and potentially in other Asian and 
developing countries.  With limited health infrastructure and resources, it would be 
particularly beneficial if programs designed to combat hypertension are guided by empirical 
data. Results of this research should be evaluated in the context of its limitations and 
strengths.  
 
B. Limitations and strengths 
This research has certain limitations. We faced challenges in the measurements of key 
variables used in the study. The 3 BP measurements averaged to represent BP for each 
survey round were taken in the same day and cannot account for day to day variations. This 
may cause regression dilution and result in attenuated results. Pertinent to the investigation 
looking at OW duration and hypertension incidence, it would have been better if we were 
able to ascertain the exact time when the women became OW and developed hypertension. 
However, continuously monitoring the sample women for over two decades would need 
unlimited resources and would considerably burden the respondents possibly resulting to 
higher attrition rates. Measurement of sodium intake is challenging. We estimated sodium 
intake using two 24-hour dietary recalls and a food frequency questionnaire focused on 
consumption of table salt and other high sodium condiments and sauces. This method is more 
prone to measurement errors compared to 24-hour urine collections, but much more practical 
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for a large population-based study. This may have resulted in the underestimation of sodium 
intake but the degree of underestimation or error was likely non-differential. Also, the 
probability of misclassifying women with high sodium intake may have been reduced by 
setting a relatively high cut-point.  We cannot establish that high sodium intake preceded the 
development of hypertension. But, it is more likely that having hypertension will result in 
reduced rather than increased sodium intake; therefore reverse causation will more likely bias 
the estimates to the null. 
Generalizability of results may be limited by reduction in sample size due to attrition 
and to the methods used in this research. To model five-year cumulative incidence of 
hypertension, we only included women who were not hypertensive in 2002 and were 
followed-up in 2007. For the analyses involving genetic variants, the sample was limited to 
women who provided blood samples in the 2005 survey and who did not have an apparent 
first degree relative in the study. However, the main reason for attrition is migration outside 
Metropolitan Cebu and we have no sufficient reason to believe that this is associated with 
having hypertension, genotype distribution or amount of sodium intake. Also, estimates 
weighted by the reciprocal of the probability of being in the study sample were not 
considerably different from those of un-weighted analyses suggesting no significant attrition 
bias. Regarding the analyses involving genetic variants, different allele frequencies make it 
difficult to compare and transfer the results of one study population to another. However, we 
found that the distributions of the selected gene variants were comparable to other East 
Asians.  
 Despite these limitations, this research has numerous strengths anchored on our use of 
the rich and potentially unique CLHNS dataset. We are not aware of any longitudinal study 
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in developing and transitional countries that have the time depth and number of follow-ups 
that the CLHNS has. This is the first study that used incident hypertension and repeatedly 
measured weight and height in investigating the relationship of OW duration and 
hypertension. We were able to ensure that the entire duration of OW occurred before the 
development of hypertension, thus allowing us to better establish temporality and infer 
causality compared to previous studies which were all cross-sectional. Our use of measured 
weight and height collected over two decades of adult life using the same protocol reduces 
measurement error.  
 We are the first to estimate the magnitude of a sodium effect on hypertension risk 
among Filipinos who consume high amounts of sodium and have been suggested to be 
sodium-sensitive. By having genetic information on the selected variants, we add to the scant 
but important body of literature that examined gene-gene and gene-environment interactions 
that potentially contribute to our understanding of the complexity of hypertension, especially 
among Asians in developing countries.  We would not have uncovered the potential role of 
ACE I/D and ADD1 Gly460Trp polymorphisms in hypertension if differential effects by age 
were not explored. Moreover, we showed heterogeneity of the effect of sodium consumption 
on hypertension according to ADD1 Gly460Trp polymorphism and known environmental 
hypertension risk factors. With rich dietary, anthropometric, demographic and lifestyle data 
we were able to assess and adjust for confounding of other variables. 
 
C. Public health significance 
Our study has strong public health significance. First, CVD is now the leading cause 
of morbidity and mortality in the world and hypertension accounts for about half of the CVD 
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burden. Alarmingly, the rate of hypertension continues to rise, especially in lower income 
countries that are overburdened by both communicable and chronic diseases. Second, the 
demographic and health trends in the Philippines exemplify those of other developing 
countries undergoing the nutrition transition: (a) heart and vascular diseases are the leading 
causes of death in the country; and (b) there is a high prevalence (with an increasing trend) in 
CVD risk factors. Third, Asians are of special concern because they have the most rapid 
increases in obesity and obesity-related diseases worldwide, and they tend to develop CVD 
risk factors at lower BMI thresholds. Moreover, Asians tend to consume high amounts of 
sodium possibly increasing their likelihood of developing hypertension. We showed that 
Filipinos have distributions of potentially high risk genotypes and sources of dietary sodium 
that are comparable to other East Asians. Fourth, we investigated important modifiable and 
non-modifiable risk factors that have been suggested by previous studies, albeit mostly from 
developed countries. Thus, our findings can provide critical information necessary for 
hypertension prevention efforts not only for the Philippines but also for other developing 
countries, especially for East Asians.  
More specifically, our results suggest that for a more comprehensive program aimed 
at preventing or reducing hypertension prevalence in the population, efforts to prevent weight 
gain and accumulation of excess weight earlier in life and to reduce sodium intake should be 
incorporated and intensified. We showed evidence that in addition to presence of OW, the 
length of exposure to excess weight may increase risk of developing hypertension. However, 
owing to the prevalence of hypertension in women who are not OW, efforts to reduce 
hypertension should also focus on the benefits of reducing sodium intake among women who 
are not OW or who have never been OW. Our results indicate that the effects of high sodium 
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intake are enhanced in these groups of women who are most likely presumed to be at low 
risk for hypertension.  Moreover, programs for reducing salt consumption in the Philippines 
and other East Asian countries could concentrate on encouraging the public to reduce the use 
of added salt and other salty condiments in the household more than or in addition to 
reducing sodium used during food processing (such as advocated in the US).  Since salt has 
been iodized to prevent iodine deficiency in the Philippines and other countries, alternate 
strategies or iodization of other commonly consumed foods should be promoted to avoid 
potentially conflicting public health messages.  
 
D. Direction for future research 
  Potential mechanisms suggested for the relationship between OW duration and the 
risk of developing hypertension include hyperinsulinemia and insulin resistance. With 
CLHNS data on these measures, we can explore this hypothesis. 
 Another major CVD risk factor raising worldwide concern is diabetes mellitus, 
particularly type 2 diabetes. Diabetes increases the risk of fatal CVDs two- to three-fold.  
Thus, we would like to conduct similar analyses using the exposures and methods employed 
in this research but with diabetes as the main outcome.  
 The use of dietary patterns rather than individual nutrients in assessing diet and health 
relationships has been increasing. Advocates of using foods versus nutrients argue that 
discussing diet in terms of food group intakes are easier to translate into intervention 
messages. Furthermore, environmental and cultural factors define diet patterns which in turn 
affect nutrient intakes. Noteworthy is the lack of studies on dietary patterns and health 
outcomes from developing countries, much less from Asia. We propose to identify dietary 
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patterns through cluster analysis and to examine their effects on hypertension and type 2 
diabetes. We may also identify patterns that cluster with high sodium intake. In addition to 
contributing to the scant literature on dietary pattern-CVD risk factors in Asia, the study can 
provide critical information for more tailored disease prevention efforts in the country. We 
can then assess the appropriateness of dietary public health messages which are patterned 
mostly from studies involving Western populations.  
 Hypertension and diabetes frequently coexist, further magnifying CVD-risk. Their 
coexistence may modify the influence of CVD-risk factors. For example, the effect of dietary 
salt intake on hypertension is highest on individuals with diabetes, obesity, and renal 
deficiencies. On the other hand, the use of some hypertensive medications such as beta-
blockers may increase the risk of developing diabetes. In addition to identifying weight and 
dietary patterns associated with hypertension or diabetes, we can examine whether the 
strength and direction of the weight history and dietary effects are influenced by the 
independence or coexistence of these morbidities. 
 We will continue to explore effects of novel gene variants that will be discovered by 
high-density association studies and genome-wide association studies on the risk of 
hypertension and diabetes.  
 In summary, this research found that the duration of being OW, selected genetic 
variants and sodium intake influence hypertension risk in adult Filipino women. We 
observed potential gene-gene and gene-environment interactions and support the importance 
of conducting context-dependent analyses. By examining key modifiable and non-modifiable 
risk factors, results of this research can be used to design a more comprehensive hypertension 
prevention program in the Philippines and possibly in other Asian and developing countries. 
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We propose to employ the methods used in this research to investigate type 2 diabetes, 
another major CVD risk factor that tend to co-occur with hypertension.  
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